Document:

EX-10.2

 Exhibit 10.2 
 FOURTH AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT 
 This Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement (the “Agreement”) is made and entered into as of this 20th day of November, 2013 (the “Effective Date”), by
and among Roka Bioscience, Inc., a Delaware corporation (the “Company”), those holders of the Company’s Common Stock listed on Exhibit A hereto (referred to hereinafter as the “Common Holders” and
each individually as a “Common Holder”), the persons and entities listed on Exhibit B hereto (referred to hereinafter as the “Investors” and each individually as an “Investor”, and
together with the Common Holders, the “Stockholders”) and each other person or entity who shall, subsequent to the date hereof, join in and become a party to this Agreement by executing and delivering to the Company an instrument of
accession substantially in the form of Exhibit C attached hereto (an “Instrument of Accession”). 

RECITALS 

WHEREAS, certain of the Investors purchased shares of the Company’s Series B Preferred Stock, par value $0.001 per share (the
“Series B Stock”), pursuant to that certain Series B Preferred Stock Purchase Agreement, dated as of September 10, 2009; 
 WHEREAS, in connection with the issuance of the Series B Stock, the Company, the Common Holders and certain of the Investors entered into a Right of First Refusal and Co-Sale Agreement, dated as of
September 10, 2009; 
 WHEREAS, certain of the Investors and the Company entered into that certain Series C
Preferred Stock Purchase Agreement, dated as of April 29, 2011, to purchase shares of the Company’s Series C Preferred Stock, $0.001 par value per share (“Series C Stock”); 

WHEREAS, in connection with the issuance of the Series C Stock, the Company, the Common Holders and certain of the Investors
entered into an Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of April 29, 2011; 

WHEREAS, certain of the Investors and the Company entered into that certain Series D Preferred Stock Purchase Agreement, dated as
of December 19, 2011, to purchase shares of the Company’s Series D Preferred Stock, $0.001 par value per share (the “Series D Stock”); and 
 WHEREAS, in connection with the issuance of the Series D Stock, the Company, the Common Holders and certain of the Investors entered into a Second Amended and Restated Right of First Refusal and
Co-Sale Agreement, dated as of December 19, 2011; 
 WHEREAS, certain of the Investors and the Company
entered into that certain Series E Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof (the “Initial Series E Purchase Agreement”), to purchase shares of the Company’s Series E Preferred Stock, $0.001
par value per share (the “Series E Stock”); and 
 WHEREAS, in connection with the issuance of the
Series E Stock pursuant to the Initial Series E Purchase Agreement, the Company, the Common Holders and certain of the Investors (the “Existing Holders”) entered into a Third Amended and Restated Right of First Refusal and Co-Sale
Agreement, dated as of June 13, 2013 (the “Existing Right of First Refusal and Co-Sale Agreement”); 

 WHEREAS, certain of the Investors and the Company entered into that certain Series E
Preferred Stock Purchase Agreement, dated as of the date hereof (the “Series E Purchase Agreement”), to purchase shares of the Company’s Series E Stock; 
 WHEREAS, the Company, the Investors and the Common Holders desire to amend and restate the Existing Right of First Refusal and Co-Sale Agreement in its entirety in accordance with Section 6.4
thereof; 
 WHEREAS, the Existing Holders executing this Agreement are the holders of a sufficient number of
shares of capital stock of the Company to amend and restate the Existing Right of First Refusal and Co-Sale Agreement in its entirety in accordance with Section 6.4 thereof. 

WHEREAS, the obligations in the Series E Purchase Agreement are conditioned upon the execution and delivery of this Agreement;
and 
 WHEREAS, in order to induce the Company, the Investors and the Common Holders to approve the issuance of
the Series E Stock and to induce the Investors to invest funds in the Company pursuant to the Purchase Agreement, the Investors, the Common Holders and the Company hereby agree that this Agreement shall govern the rights of the Investors and the
Common Holders with respect to the transfer of Common Stock issuable or issued to them and certain other matters as set forth herein. 
 NOW, THEREFORE, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in this Agreement and in the Series E Purchase Agreement, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Existing Holders hereby agree that the Existing Right of First Refusal and Co-Sale Agreement shall be amended and restated in its entirety
by this Agreement, each of the Investors party to the Series E Purchase Agreement hereby agrees to be bound by this Agreement, and each the parties hereto further agrees as follows: 

AGREEMENT 
  

	1.	GENERAL. 

 1.1
Definitions. Unless otherwise defined herein, as used in this Agreement the following terms shall have the following respective meanings: 
 (a) “Affiliate(s)” means any person or entity directly or indirectly controlling, controlled by or under common control with another person or entity. 

(b) “Common Stock” means, collectively, the Series A Common Stock, $0.001 par value per share, of the Company, and the
Series B Common Stock, $0.001 par value per share, of the Company. 

  
 -2-

 (c) “Preferred Stock” means, collectively, the Series B Stock, the Series C
Stock, Series D Stock and the Series E Stock. 
 (d) “Shares” means the Common Stock and Preferred Stock held
by the Common Holders and the Investors and their permitted assigns. 
 (e) “Transfer” means any sale,
assignment, encumbrance, hypothecation, pledge, conveyance in trust, gift, transfer by request, devise or descent, or other transfer or disposition of any kind, including, but not limited to, transfers to receivers, levying creditors, trustees or
receivers in bankruptcy proceedings or general assignees for the benefit of creditors, whether voluntary or by operation of law, directly or indirectly. 
 1.2 Other Defined Terms. Each of the following terms shall have the meanings ascribed to such terms in the section set forth opposite such term: 

 

			
	  	  	 Section(s)

		
	“Agreement”	  	Preamble
		
	“Common Holders”	  	Preamble
		
	“Company”	  	Preamble
		
	“Co-Sale Notice”	  	2.3(a)
		
	“Co-Sale Participant”	  	2.3(c)
		
	“Effective Date”	  	Preamble
		
	“Existing Holders”	  	Recitals
		
	“Existing Right of First Refusal and Co-Sale Agreement”	  	Recitals
		
	“Initial Series E Purchase Agreement”	  	Recitals
		
	“Instrument of Accession”	  	Preamble
		
	“Investor(s)”	  	Preamble
		
	“Investor Notice”	  	2.2(a)
		
	“Investor Shares”	  	2.3(a)
		
	“Notice”	  	2.1
		
	“Overallotment Notice”	  	2.2(c)
		
	“Participating Investors”	  	2.2(a)

  
 -3-

			
	“Participating Investors Overallotment Notice”	  	2.2(c)
		
	“Prohibited Transaction”	  	4.1
		
	“Prohibited Transfer”	  	4.2(a)
		
	“Selling Stockholder”	  	2.1
		
	“Selling Stockholder Shares”	  	2.1
		
	“Series B Stock”	  	Recitals
		
	“Series C Stock”	  	Recitals
		
	“Series D Stock”	  	Recitals
		
	“Series E Stock”	  	Recitals
		
	“Series E Purchase Agreement”	  	Recitals
		
	“Stockholders”	  	Preamble
		
	“Transferee-Selling Stockholder”	  	2.4(a)

  

	2.	RIGHT OF FIRST REFUSAL AND CO-SALE. 

 2.1 Notice of Transfer. If any Common Holder or Investor proposes to Transfer any of its or his Shares (each a “Selling Stockholder”), then such Selling Stockholder shall promptly
give written notice (the “Notice”) simultaneously to the Company and to each of the Investors at least 45 days prior to the closing of such Transfer; provided, however, that, notwithstanding such 45-day period, no such
Transfer shall be effected until the terms of this Section 2 have been fully complied with. The Notice shall describe in reasonable detail the proposed Transfer including, without limitation, the number of Shares to be Transferred (the
“Selling Stockholder Shares”), the nature of such Transfer, the consideration to be paid, and the name and address of each prospective transferee. In the event that the Transfer is being made pursuant to the provisions of
Section 2.4, the Notice shall state under which clause of Section 2.4 the Transfer is being made. 
 2.2 Investor
Right of First Refusal. 
 (a) Each Investor shall have the right, exercisable upon written notice to the Selling
Stockholder (the “Investor Notice”) within ten days after the receipt of the Notice, to purchase its pro rata share of the Selling Stockholder Shares subject to the Notice and on the same terms and conditions as set forth therein.
Except as set forth in Section 2.2(c), the Investors who so exercise their rights (the “Participating Investors”) shall effect the purchase of the Selling Stockholder Shares, including payment of the purchase price, not more
than ten business days after delivery of the Investor Notice, and at such time the Selling Stockholder shall deliver to the Participating Investors the certificate(s) representing the Selling Stockholder Shares to be purchased by the Participating
Investors, each certificate to be properly endorsed for Transfer. 

  
 -4-

 (b) For the purposes of this section, each Investor’s pro rata share shall be
equal to the product obtained by multiplying (i) the aggregate number of shares of Selling Stockholder Shares covered by the Notice and (ii) a fraction, the numerator of which is the number of shares of Common Stock issued or issuable upon
the conversion or exercise of Preferred Stock or other rights to acquire shares of Common Stock held by the Participating Investor at the time of the Notice, and the denominator of which is the total number of shares of Common Stock issued or
issuable upon the conversion or exercise of Preferred Stock or other rights to acquire shares of Common Stock held by all Investors at the time of the Notice. 
 (c) In the event that not all of the Investors elect to purchase their pro rata share of the Selling Stockholder Shares available pursuant to their rights under Section 2.2(a) within the time
period set forth therein, then the Selling Stockholder shall promptly give written notice to each of the Participating Investors (the “Overallotment Notice”), which shall set forth the number of shares of Selling Stockholder Shares
not purchased by the other Investors, and shall offer such Participating Investors the right to acquire such unsubscribed shares. Each Participating Investor shall have five days after receipt of the Overallotment Notice to deliver a written notice
to the Selling Stockholder (the “Participating Investors Overallotment Notice”) indicating the number of unsubscribed shares that such Participating Investor desires to purchase, and each such Participating Investor shall be
entitled to purchase such number of unsubscribed shares on the same terms and conditions as set forth in the Notice. In the event that the Participating Investors desire, in the aggregate, to purchase in excess of the total number of available
unsubscribed shares, then the number of unsubscribed shares that each Participating Investor may purchase shall be reduced on a pro rata basis. For purposes of this Section 2.2(c) the denominator described in clause (ii) of subsection
2.2(b) above shall be the total number of shares of Common Stock issued or issuable upon the conversion or exercise of Preferred Stock or other rights to acquire shares of Common Stock held by the Participating Investors at the time of the Notice.
The Participating Investors shall then effect the purchase of the Selling Stockholder Shares, including payment of the purchase price, not more than five days after delivery of the Participating Investors Overallotment Notice, and at such time, the
Selling Stockholder shall deliver to the Participating Investors the certificates representing the Selling Stockholder Shares to be purchased by the Participating Investors, each certificate to be properly endorsed for Transfer. 

2.3 Right of Co-Sale. 
 (a) In the event the Investors fail to exercise their respective rights to purchase all of the Selling Stockholder Shares subject to Section 2.2 hereof, following the exercise or expiration of
the rights of purchase set forth in Section 2.2, then the Selling Stockholder shall deliver to the Company and each Investor written notice (the “Co-Sale Notice”) that each Investor shall have the right, exercisable upon
written notice to such Selling Stockholder with a copy to the Company within 15 days after receipt of the Co-Sale Notice, to participate in such Transfer of Selling Stockholder Shares on the same terms and conditions. Such notice shall indicate the
number of Shares up to that number of shares determined under Section 2.3(b) such investor wishes to sell under his or its right to participate (the “Investor Shares”). To the extent one or more of the Investors exercise such
right of participation in accordance with the terms and conditions set forth below, the number of shares of Selling Stockholder Shares that such Selling Stockholder may sell in the transaction shall be correspondingly reduced. 

  
 -5-

 (b) Each Investor may sell all or any part of that number of shares equal to the
product obtained by multiplying (x) the aggregate number of shares of Selling Stockholder Shares covered by the Co-Sale Notice and not purchased by Investors pursuant to Section 2.2 by (y) a fraction, the numerator of which is the
number of shares of Common Stock issued or issuable upon the conversion or exercise of Preferred Stock or other rights to acquire shares of Common Stock held by such Investor at the time of the Co-Sale Notice and the denominator of which is the
total number of Shares held by such Selling Stockholder (excluding shares purchased by the Investors pursuant to Section 2.2) plus the number of shares of Common Stock issued or issuable upon the conversion or exercise of Preferred Stock or
other rights to acquire shares of Common Stock held by all Investors at the time of the Co-Sale Notice. 
 (c) Each
Investor who elects to participate in the Transfer pursuant to this Section 2.3 (a “Co-Sale Participant”) shall effect its participation in the Transfer by promptly delivering to such Selling Stockholder for Transfer to the
prospective transferee one or more certificates, properly endorsed for Transfer, which represent: 
 (i) the number of shares
of Common Stock which such Co-Sale Participant elects to sell; or 
 (ii) the type and number of shares of Preferred Stock
which is at such time convertible into the number of shares of Common Stock which such Co-Sale Participant elects to sell; provided, however, that if the prospective purchaser objects to the delivery of Preferred Stock in lieu of
Common Stock, such Co-Sale Participant shall convert such Preferred Stock into Common Stock and deliver Common Stock as provided in Section 2.3(c)(i) above. The Company agrees to make any such conversion concurrent with and contingent upon the
actual Transfer of such shares to the transferee. 
 (d) The stock certificate or certificates that the Co-Sale
Participant delivers to such Selling Stockholder pursuant to Section 2.3(c) shall be Transferred to the prospective purchaser in consummation of the sale of the Common Stock or Preferred Stock, as the case may be, pursuant to the terms and
conditions specified in the Co-Sale Notice, and the Selling Stockholder shall concurrently therewith remit to such Co-Sale Participant that portion of the sale proceeds to which such Co-Sale Participant is entitled by reason of its participation in
such sale. To the extent that any prospective purchaser or purchasers prohibits such assignment or otherwise refuses to purchase shares or other securities from a Co-Sale Participant exercising its rights of co-sale hereunder, such Selling
Stockholder shall not sell to such prospective purchaser or purchasers any Selling Stockholder Shares unless and until, simultaneously with such sale, such Selling Stockholder shall purchase such shares or other securities from such Co-Sale
Participant on the same terms and conditions specified in the Co-Sale Notice. Any purchasers of the Common Stock or Preferred Stock shall enter into an Instrument of Accession, agreeing to be bound by and comply with all provisions of this
Agreement, as if it were a Common Holder or a holder of Preferred Stock, as the case may be, hereunder. 

  
 -6-

 (e) The exercise or non-exercise of the rights of any Investor hereunder to
participate in one or more Transfers of Selling Stockholder Shares made by any Selling Stockholder shall not adversely affect its right to participate in subsequent Transfers of Selling Stockholder Shares subject to this Section 2. 

(f) To the extent that the Investors do not elect to participate in the sale of the Selling Stockholder Shares subject to the
Co-Sale Notice, such Selling Stockholder may, not later than 60 days following delivery to the Company of the Co-Sale Notice, enter into an agreement providing for the closing of the Transfer of such Selling Stockholder Shares covered by the Co-Sale
Notice within 30 days of such agreement on terms and conditions not materially more favorable to the Selling Stockholder than those described in the Co-Sale Notice. Any proposed Transfer on terms and conditions materially more favorable than those
described in the Co-Sale Notice, as well as any subsequent proposed Transfer of any of the Selling Stockholder Shares by a Selling Stockholder, shall again be subject to the first refusal and co-sale rights of the Investors and shall require
compliance by a Selling Stockholder with the procedures described in this Section 2. 
 2.4 Exempt Transfers. 

(a) Notwithstanding the foregoing, the first refusal and co-sale rights of the Investors set forth in Section 2 above shall
not apply to (i) any Transfer without consideration to the Selling Stockholder’s ancestors, descendants or spouse or to trusts for the benefit of such persons or the Selling Stockholder, (ii) any pledge of Selling Stockholder Shares
made pursuant to a bona fide loan transaction that creates a mere security interest, (iii) any bona fide gift, (iv) any Transfer to an Affiliate of such Selling Stockholder, or (v) any Transfer by a Selling Stockholder to one or more
of its members, stockholders, limited partners or general partners; provided that in the event of any Transfer made pursuant to one of the exemptions provided by clauses (i), (ii), (iii), (iv) and (v), (A) the Selling Stockholder shall
inform the Investors of such Transfer prior to effecting it and (B) the transferee shall enter into an Instrument of Accession, agreeing to be bound by and comply with all provisions of this Agreement, as if it were an original Selling
Stockholder hereunder. Such Transferred Selling Stockholder Shares shall remain “Selling Stockholder Shares” hereunder, and such transferee shall be treated as a “Selling Stockholder” for purposes of this Agreement, except that
such transferee may not Transfer shares pursuant to Section 2.4(a)(i) hereof. 
 (b) Notwithstanding
Section 2.4(a), the provisions of this Section 2 shall not apply to the sale of any Shares to the public pursuant to a registration statement filed with, and declared effective by, the Commission under the Securities Act. 

(c) This Agreement is subject to, and shall in no manner limit the right which the Company may have to repurchase securities from
the Selling Stockholder pursuant to a stock restriction agreement or other agreement between the Company and the Selling Stockholder. 
  

	3.	TERMINATION. 

 3.1
Events of Termination. This Agreement shall continue in full force and effect from the date hereof through the earliest of the following dates, on which date it shall terminate in its entirety: (a) the date of the closing of a Qualified IPO
(as defined in the 

  
 -7-

 
Company’s Sixth Amended and Restated Certificate of Incorporation); or (b) the date of the closing of a Liquidation Event (as defined in the Company’s Sixth Amended and Restated
Certificate of Incorporation). In addition, first refusal and co-sale rights set forth in Section 2 shall terminate as to any Investor as of the date such Investor no longer holds any shares of Preferred Stock. 

 

	4.	PROHIBITED TRANSFERS. 

4.1 Call Option. In the event of a prohibited transfer in violation of Section 2.2 hereof (a “Prohibited
Transaction”), the Investors shall have the option to purchase from the transferee of the Shares transferred in violation of Section 2.2, the number of shares that the Investors would have been entitled to purchase had such Prohibited
Transaction been effected in accordance with Section 2.2 hereof, on the following terms and conditions: 
 (a) the
price per share at which the shares are to be purchased by the Investors shall be equal to the price per share paid to such Stockholder by the third party purchaser or purchasers of such Shares that are subject to the Prohibited Transaction; and

 (b) the Stockholder effecting such Prohibited Transaction shall reimburse the Investors for any expenses, including
legal fees and expenses, incurred in effecting such purchase. 
 4.2 Put Option. 

(a) In the event that a Stockholder should sell any Shares in contravention of the co-sale rights of each Investor under
Section 2.3 of this Agreement (a “Prohibited Transfer”), each Investor, in addition to such other remedies as may be available at law, in equity or hereunder, shall have the put option provided below, and such Stockholder shall
be bound by the applicable provisions of such option. 
 (b) In the event of a Prohibited Transfer, each Investor shall
have the right to sell to such Stockholder the type and number of shares of capital stock equal to the number of shares each Investor would have been entitled to transfer to the purchaser under Section 2.3 hereof had the Prohibited Transfer
been effected pursuant to and in compliance with the terms hereof. Such sale shall be made on the following terms and conditions: 
 (i) The price per share at which the shares are to be sold to the Stockholder shall be equal to the price per share paid by the purchaser to such Stockholder in such Prohibited Transfer. The Stockholder
shall also reimburse each Investor for any and all fees and expenses, including legal fees and expenses, incurred in connection with the exercise or the attempted exercise of the Investor’s rights under Section 2.3. 

(ii) Within ninety days after the date on which an Investor received notice of the Prohibited Transfer or otherwise became aware of the
Prohibited Transfer, such Investor shall, if exercising the option created hereby, deliver to the Stockholder the certificate or certificates representing the shares to be sold, each certificate to be properly endorsed for transfer. 

(iii) Such Stockholder shall, upon receipt of the certificate or certificates for the shares to be sold by an Investor pursuant to this
Section 4.2, pay the aggregate purchase price therefor and the amount of reimbursable fees and expenses, as specified in Section 4.2(b)(i), in cash or by other means acceptable to the Investor. 

  
 -8-

	5.	LEGEND. 

 5.1 Each
certificate representing Shares now or hereafter owned by a Stockholder or issued to any person in connection with a Transfer pursuant to Section 2.4 hereof shall be endorsed with substantially the following legend: 

“THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS
OF A FOURTH AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT BY AND BETWEEN THE STOCKHOLDER, THE COMPANY AND CERTAIN HOLDERS OF STOCK OF THE COMPANY. A COPY OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF
THE COMPANY.” 
 5.2 The Stockholders agree that the Company may instruct its transfer agent to impose transfer
restrictions on the shares represented by certificates bearing the legend referred to in Section 5.1 above to enforce the provisions of this Agreement and the Company agrees to promptly do so. The legend shall be removed at the request of any
Stockholder following termination of this Agreement. 
  

	6.	MISCELLANEOUS. 

 6.1
Further Action. If and whenever any of its Shares are Transferred, the Stockholder Transferring such shares, or the personal representative of such Stockholder, shall do all things and execute and deliver all documents and make all Transfers,
and cause any transferee of such Shares to do all things and execute and deliver all documents, as may be reasonably necessary to consummate such sale in a manner and pursuant to terms that are consistent with this Agreement. 

6.2 Specific Performance. The parties hereto hereby declare that it is impossible to measure in money the damages which will
accrue to a party hereto or to their heirs, personal representatives or assigns by reason of a failure to perform any of the obligations under this Agreement and agree that the terms of this Agreement shall be specifically enforceable. If any party
hereto or his heirs, personal representatives or assigns institutes any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is brought hereby waives the claim or defense therein that
such party or such personal representative has an adequate remedy at law, and such person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists. 

6.3 Governing Law. This Agreement shall be governed by, and construed under, the laws of the State of Delaware, without regard to
principles of conflict of laws. The parties agree that any action brought by either party under or in relation to this 

  
 -9-

 
Agreement, including without limitation to interpret or enforce any provision of this Agreement, shall be brought in, and each party agrees to and does hereby submit to the jurisdiction and venue
of, any state or federal court located in the State of New Jersey. 
 6.4 Amendment or Waiver. This Agreement may be
amended or modified (or provisions of this Agreement waived either generally or in a particular instance and either retroactively or prospectively) only with the written consent of (a) the Company (with the approval of the Board) and
(b) the holders of at least 51% of the votes attributable to the then outstanding shares of Series E Stock, Series D Stock, Series C Stock and Series B Stock, voting together as a single class. Any amendment or waiver so effected shall be
binding upon the Company, each of the parties hereto and any assignee of any such party. 
 6.5 Severability. In case any
provision of this Agreement shall be invalid, illegal or unenforceable, it shall to the extent practicable, be modified so as to make it valid, legal and enforceable and to retain as nearly as practicable the intent of the parties and the business
agreement represented by such invalidated term, and the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 6.6 Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, successors, assigns, administrators, executors and other
legal representatives, and each permitted transferee of Shares who shall be assigned rights under this Agreement in accordance with the requirements of this Agreement. 
 6.7 Additional Shares. In the event that subsequent to the Effective Date any shares or other securities are issued on, or in exchange for, any of the Shares by reason of any stock dividend, stock
split, combination of shares, reclassification or the like, such shares or securities shall be deemed to be Shares for purposes of this Agreement. 
 6.8 Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together shall constitute one and the same agreement.
Facsimile copies hereof may be executed as counterpart originals. 
 6.9 No Waiver. No waivers of any breach of this
Agreement extended by any party hereto to any other party shall be construed as a waiver of any rights or remedies of any other party hereto or with respect to any subsequent breach. 

6.10 Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon
personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if received during normal business hours of the recipient; if not, then on the next business day (c) five days after deposit with the
United States Post Office, by registered or certified mail, return receipt requested, postage prepaid, or (d) one business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with verification of
receipt. All communications shall be sent to the party to be notified at the address as set forth on the signature pages hereof or at such other address as such party may designate by 10 days advance written notice to the other parties hereto.

  
 -10-

 6.11 Entire Agreement. This Agreement (including the Exhibits and Schedules hereto)
constitutes the full and entire understanding and agreement among the parties with regard to the subject matter hereof and supersedes all prior and contemporaneous agreements or understandings with respect thereto, including, without limitation, the
Existing Right of First Refusal and Co-Sale Agreement. 
 [Remainder of Page Intentionally Left Blank] 

  
 -11-

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Right of First Refusal and Co-Sale Agreement as of the date first above written. 
  

					
	 COMPANY:

	
	ROKA BIOSCIENCE, INC.
		
	By:	 	 /s/ Paul Thomas

		 	Name:	 	Paul Thomas
		 	Title:	 	President and CEO

  

			
	Address:	 	20 Independence Boulevard
		 	4th Floor
		 	Warren, New Jersey 07059
	Fax:	 	
	Email:	 	

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

	
	COMMON HOLDERS:
	
	 /s/ Paul Thomas

	Paul Thomas
	
	 /s/ Steven Sobieski

	Steven Sobieski

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	INVESTORS:
	
	ORBIMED PRIVATE INVESTMENTS III, LP
	
	BY: ORBIMED CAPITAL GP III, LLC
		 	ITS GENERAL PARTNER
		
	By:	 	 /s/ Jonathan Silverstein

	Name:	 	Jonathan Silverstein
	Title:	 	Member
	
	ORBIMED ASSOCIATES III, LP
	
	BY: ORBIMED ADVISORS, LLC
		 	ITS GENERAL PARTNER
		
	By:	 	 /s/ Jonathan Silverstein

	Name:	 	Jonathan Silverstein
	Title:	 	Member

  

			
	Address:	 	601 Lexington Ave. 54th Floor
	Address:	 	New York, NY 10022
	Fax:	 	212-739-6444
	Email:	 	

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	NEW ENTERPRISE ASSOCIATES 13, LIMITED PARTNERSHIP
		
	BY:	 	NEA PARTNERS 13, LIMITED PARTNERSHIP,
		 	ITS GENERAL PARTNER
		
	BY:	 	NEA 13 GP, LTD,
		 	ITS GENERAL PARTNER
		
	By:	 	 /s/ Louis Citron

	Name:	 	Louis Citron
	Title:	 	Chief Legal Officer
	
	NEA VENTURES 2009, LIMITED PARTNERSHIP
		
	By:	 	 /s/ Louis Citron

	Name:	 	Louis Citron
	Title:	 	Vice President

  

			
	Address:	 	1754 Greenspring Drive, Suite 600
	Address:	 	Timonium, MD 21093
	Fax:	 	
	Email:	 	

  

			
	TPG BIOTECHNOLOGY PARTNERS III, L.P.
		
	BY:	 	TPG BIOTECHNOLOGY GENPAR III, L.P.,
		 	ITS GENERAL PARTNER
		
	BY:	 	TPG BIOTECHNOLOGY GENPAR III ADVISORS, LLC
		 	ITS GENERAL PARTNER
		
	By:	 	 /s/ Ronald Cami

	Name:	 	Ronald Cami
	Title:	 	Vice President

  

			
	Address:	 	345 California St., Suite 3300
	Address:	 	San Francisco, CA 94104
	Fax:	 	
	Email:	 	

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	AISLING CAPITAL III, LP
	
	 /s/ Lloyd Appel

	Name:	 	Lloyd Appel
	Title:	 	CFO

  

			
	Address:	 	888 Seventh Avenue, 30th Floor
		 	New York, NY 10106
	Attn:	 	Chief Financial Officer
	Fax:	 	212 651 6379
	
	With a required copy to:
	McDermott Will & Emery LLP
	340 Madison Avenue
	New York, NY 10173-1922
	Attn: Todd Finger
	Fax: 212 547 5444

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	FIDELITY MT. VERNON STREET TRUST:
	FIDELITY GROWTH COMPANY FUND
		
	By:	 	 /s/ Adrien Deberghes

	Name:	 	Adrien Deberghes
	Title:	 	Deputy Treasurer

  

			
	Address:	 	Ball & Co
		 	C/o Citibank N.A/Custody
		 	IC&D Lock Box
		 	P.O Box 7247-7057
		 	Philadelphia, P.A 19170-7057

  

			
	FIDELITY ADVISOR SERIES VII:
	FIDELITY ADVISOR HEALTH CARE FUND
		
	By:	 	 /s/ Adrien Deberghes

	Name:	 	Adrien Deberghes
	Title:	 	Deputy Treasurer

  

			
	Address:	 	M.Gardiner & Co
		 	C/O JPMorgan Chase Bank, N.A
		 	P.O. Box 35308
		 	Newark, NJ 07101-8006

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	FIDELITY SELECT PORTFOLIOS:
	MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO
		
	By:	 	 /s/ Adrien Deberghes

	Name:	 	Adrien Deberghes
	Title:	 	Deputy Treasurer

  

			
	Address:	 	Brown Brothers Harriman & Co.
		 	525 Washington Blvd
		 	Jersey City NJ 07310
		 	Attn: Michael Lerman 15th Floor
		 	Corporate Actions

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

			
	LEERINK SWANN HOLDINGS, LLC
		
	By:	 	 /s/ Jeffrey A. Leerink

	Name:	 	Jeffrey A. Leerink
	Title:	 	Chief Executive Officer

  

			
	Address:	 	1 Federal Street, Boston, MA 02110
		
	Copies to:	 	Timothy A. G. Gerhold, General Counsel
		 	Leerink Swann LLC
		 	1 Federal Street, Boston MA 02110

  

			
	LEERINK SWANN CO-INVESTMENT FUND, LLC
		
	By:	 	 /s/ Jeffrey A. Leerink

	Name:	 	Jeffrey A. Leerink
	Title:	 	Manager

  

			
	Address:	 	1 Federal Street, Boston, MA 02110
		
	Copies to:	 	Timothy A. G. Gerhold, General Counsel
		 	Leerink Swann LLC
		 	1 Federal Street, Boston MA 02110

  

[Signature Page to Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement] 

 EXHIBIT A 

LIST OF COMMON HOLDERS 
  

					
	 Holders
	  	Common Stock Held	 
	 Paul Thomas
	  	 	6,250,000	  
		
	 Steven Sobieski
	  	 	1,283,325	  

 EXHIBIT B 

LIST OF INVESTORS 

OrbiMed Private Investments III, LP 
 OrbiMed
Associates III, LP 
 New Enterprise Associates 13, Limited Partnership 
 NEA Ventures 2009, Limited Partnership 
 TPG Biotechnology Partners III, L.P. 

Gen-Probe Incorporated 
 Aisling Capital III, LP

 Fidelity Mt. Vernon Street Trust: Fidelity Growth Capital Fund 
 Fidelity Advisor Series VII: Fidelity Advisor Health Care Fund 
 Fidelity Select Portfolios:
Medical Equipment and Systems Portfolio 
 Leerink Swann Holdings, LLC 
 Leerink Swann Co-Investment Fund, LLC 

 EXHIBIT C 

INSTRUMENT OF ACCESSION 
 Reference is made to that certain Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement dated as of November     , 2013, a copy of which is attached hereto (as
amended and in effect from time to time, the “Right of First Refusal and Co-Sale Agreement”), among ROKA BIOSCIENCE, INC., a Delaware corporation (the “Corporation”), and certain other parties thereto. Capitalized
terms used herein without definition shall have the respective meanings ascribed thereto in the Right of First Refusal and Co-Sale Agreement. 
 The undersigned,                     , in order to become the owner or holder of shares (the
“Acquired Shares”) of [Series B Preferred] [Series C Preferred] [Series D Preferred] [Series E Preferred] [Common] Stock hereby agrees that, from and after the date hereof, the undersigned has become [an
“Investor”][a “Common Holder”] under the Right of First Refusal and Co-Sale Agreement and is entitled to all of the benefits under, and is subject to all of the obligations, restrictions and limitations of [an
Investor] [a Common Holder] set forth in the Right of First Refusal and Co-Sale Agreement. This Instrument of Accession shall take effect and shall become a part of the Right of First Refusal and Co-Sale Agreement immediately upon execution.

 Executed as of the date set forth below under the domestic substantive laws of Delaware without giving effect to any choice
or conflict of law provision or rule that would cause the application of the domestic substantive laws of any other state. 
  

			
	Signature:	 	  

		
	Name:	 	  

		
	Address:	 	  

		
	Date:	 	  

  

			
	Accepted:
	
	[                    ]
		
	By:	 	  

	Name:	 	
	Title:	 	
	Date:EX-10.3

 Exhibit 10.3 

ROKA BIOSCIENCE, INC. 

2009 EQUITY INCENTIVE PLAN 

							
	 1.
	 	 Purpose
	  	 	1	  
	 2.
	 	 Definitions
	  	 	1	  
	 3.
	 	 Term of the Plan
	  	 	3	  
	 4.
	 	 Stock Subject to the Plan
	  	 	3	  
	 5.
	 	 Administration
	  	 	3	  
	 6.
	 	 Authorization of Grants
	  	 	4	  
	 7.
	 	 Specific Terms of Awards
	  	 	4	  
	 8.
	 	 Adjustment Provisions
	  	 	8	  
	 9.
	 	 Settlement of Awards
	  	 	11	  
	 10.
	 	 Reservation of Stock
	  	 	13	  
	 11.
	 	 No Special Employment or Other Rights
	  	 	13	  
	 12.
	 	 Nonexclusivity of the Plan
	  	 	13	  
	 13.
	 	 Termination and Amendment of the Plan
	  	 	13	  
	 14.
	 	 Notices and Other Communications
	  	 	14	  
	 15.
	 	 Governing Law
	  	 	14	  

 ROKA BIOSCIENCE, INC. 

2009 EQUITY INCENTIVE PLAN 

1. Purpose 
 This Plan is intended to
encourage ownership of Stock by employees, consultants and directors of the Company and its Affiliates and to provide additional incentive for them to promote the success of the Company’s business. The Plan is intended to be an incentive stock
option plan within the meaning of Section 422 of the Code, but not all Awards are required to be Incentive Options. 
 2. Definitions 

As used in this Plan, the following terms shall have the following meanings: 

2.1. Accelerate, Accelerated, and Acceleration, when used with respect to an Option, means that as of the time of
reference the Option will become exercisable with respect to some or all of the shares of Stock for which it was not then otherwise exercisable by its terms, and, when used with respect to Restricted Stock, means that the Risk of Forfeiture
otherwise applicable to the Stock shall expire with respect to some or all of the shares of Restricted Stock then still otherwise subject to the Risk of Forfeiture. 

2.2. Affiliate means any corporation, partnership, limited liability company, business trust, or other entity controlling, controlled
by or under common control with the Company. 
 2.3. Award means any grant or sale pursuant to the Plan of Options, Restricted Stock
or Stock Grants. 
 2.4. Award Agreement means an agreement between the Company and the recipient of an Award, setting forth
the terms and conditions of the Award. 
 2.5. Board means the Company’s Board of Directors. 

2.6. Code means the Internal Revenue Code of 1986, as amended from time to time, or any successor statute thereto, and any regulations
issued from time to time thereunder. 
 2.7. Committee means any committee of the Board delegated responsibility by the Board for the
administration of the Plan, as provided in Section 5 of this Plan. For any period during which no such committee is in existence “Committee” shall mean the Board and all authority and responsibility assigned to the Committee under the
Plan shall be exercised, if at all, by the Board. 
 2.8. Company means Roka Bioscience, Inc., a corporation organized under the laws
of the Delaware. 
 2.9. Grant Date means the date as of which an Option is granted, as determined under Section 7.1(a).

  
 1 

 2.10. Incentive Option means an Option which by its terms is to be treated as an
“incentive stock option” within the meaning of Section 422 of the Code. 
 2.11. Market Value means the value
of a share of Stock on any date as determined by the Committee. 
 2.12. Nonstatutory Option means any Option that is not an
Incentive Option. 
 2.13. Option means an option to purchase shares of Stock. 

2.14. Optionee means a Participant to whom an Option shall have been granted under the Plan. 

2.15. Participant means any holder of an outstanding Award under the Plan. 

2.16. Plan means this 2009 Equity Incentive Plan of the Company, as amended from time to time, and including any attachments or addenda
hereto. 
 2.17. Restricted Stock means a grant of sale of shares of Stock to a Participant subject to a Risk of Forfeiture.

 2.18. Restriction Period means the period of time, established by the Committee in connection with an Award of Restricted
Stock, during which the shares of Restricted Stock are subject to a Risk of Forfeiture described in the applicable Award Agreement. 
 2.19.
Risk of Forfeiture means a limitation on the right of the Participant to retain Restricted Stock, including a right in the Company to reacquire the Shares at less than their then Market Value, arising because of the occurrence
or non-occurrence of specified events or conditions. 
 2.20. Stock means common stock, par value $0.001 per share, of the Company
and such other securities as may be substituted for Stock pursuant to Section 8. 
 2.21. Stock Grant means the grant of
shares of Stock not subject to restrictions or other forfeiture conditions. 
 2.22. Stockholders’ Agreement means any
agreement by and among the holders of at least a majority of the outstanding voting securities of the Company and setting forth, among other provisions, restrictions upon the transfer of shares of Stock or on the exercise of rights appurtenant
thereto (including but not limited to voting rights). 
 2.23. Ten Percent Owner means a person who owns, or is deemed
within the meaning of Section 422(b)(6) of the Code to own, stock possessing more than 10% of the total combined voting power of all classes of stock of the Company (or any parent or subsidiary corporations of the Company, as defined in
Sections 424(e) and (f), respectively, of the Code). Whether a person is a Ten Percent Owner shall be determined with respect to an Option based on the facts existing immediately prior to the Grant Date of the Option. 

  
 2 

 3. Term of the Plan 

Unless the Plan shall have been earlier terminated by the Board, Awards may be granted under this Plan at any time in the period commencing on
the date of approval of the Plan by the Board and ending immediately prior to the tenth anniversary of the earlier of the adoption of the Plan by the Board or approval of the Plan by the Company’s stockholders. Awards granted pursuant to the
Plan within that period shall not expire solely by reason of the termination of the Plan. Awards of Incentive Options granted prior to stockholder approval of the Plan are expressly conditioned upon such approval, but in the event of the failure of
the stockholders to approve the Plan shall thereafter and for all purposes be deemed to constitute Nonstatutory Options. 
 4. Stock Subject to the Plan

 At no time shall the number of shares of Stock issued pursuant to or subject to outstanding Awards granted under the Plan (including
pursuant to Incentive Options), nor the number of shares of Stock issued pursuant to Incentive Options, exceed 5,456,221 shares of Stock; subject, however, to the provisions of Section 8 of the Plan. For purposes of applying the
foregoing limitation, (a) if any Option expires, terminates, or is cancelled for any reason without having been exercised in full, or if any Award of Restricted Stock is forfeited by the recipient or repurchased at less than its Market Value,
the shares not purchased by the Optionee or forfeited by the recipient or repurchased shall again be available for Awards to be granted under the Plan and (b) if any Option is exercised by delivering previously owned shares in payment of the
exercise price therefor, only the net number of shares, that is, the number of shares issued minus the number received by the Company in payment of the exercise price, shall be considered to have been issued pursuant to an Award granted under the
Plan. Shares of Stock issued pursuant to the Plan may be either authorized but unissued shares or shares held by the Company in its treasury. 
 5.
Administration 
 The Plan shall be administered by the Committee; provided, however, that at any time and on any one or more
occasions the Board may itself exercise any of the powers and responsibilities assigned the Committee under the Plan and when so acting shall have the benefit of all of the provisions of the Plan pertaining to the Committee’s exercise of its
authorities hereunder. Subject to the provisions of the Plan, the Committee shall have complete authority, in its discretion, to make or to select the manner of making all determinations with respect to each Award to be granted by the Company under
the Plan including the employee, consultant or director to receive the Award and the form of Award. In making such determinations, the Committee may take into account the nature of the services rendered by the respective employees, consultants, and
directors, their present and potential contributions to the success of the Company and its Affiliates, and such other factors as the Committee in its discretion shall deem relevant. Subject to the provisions of the Plan, the Committee shall also
have complete authority to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to it, to determine the terms and provisions of the respective Award Agreements (which need not be identical), and to make all other
determinations necessary or advisable for the administration of the Plan. The Committee’s determinations made in good faith on matters referred to in the Plan shall be final, binding and conclusive on all persons having or claiming any interest
under the Plan or an Award made pursuant hereto. 

  
 3 

 6. Authorization of Grants 

6.1. Eligibility. The Committee may grant from time to time and at any time prior to the termination of the Plan one or more Awards,
either alone or in combination with any other Awards, to any employee of or consultant to one or more of the Company and its Affiliates or to any non-employee member of the Board or of any board of directors (or similar governing authority) of any
Affiliate. However, only employees of the Company, and of any parent or subsidiary corporations of the Company, as defined in Sections 424(e) and (f), respectively, of the Code, shall be eligible for the grant of an Incentive Option. Further, in no
event shall the number of shares of Stock covered by Options or other Awards granted to any one person in any one calendar year exceed 25% of the aggregate number of shares of Stock subject to the Plan. 

6.2. General Terms of Awards. Each grant of an Award shall be subject to all applicable terms and conditions of
the Plan (including but not limited to any specific terms and conditions applicable to that type of Award set out in the following Section), and such other terms and conditions, not inconsistent with the terms of the Plan, as the Committee may
prescribe. No prospective Participant shall have any rights with respect to an Award, unless and until such Participant shall have complied with the applicable terms and conditions of such Award (including if applicable delivering a fully executed
copy of any agreement evidencing an Award to the Company). 
 6.3. Non-Transferabilitv of Awards. Except as otherwise
provided in this Section, Awards shall not be transferable, and no Award or interest therein may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. All of a
Participant’s rights in any Award may be exercised during the life of the Participant only by the Participant or the Participant’s legal representative. However, the Committee may, at or after the grant of an Award of a Nonstatutory
Option, or shares of Restricted Stock, provide that such Award may be transferred by the recipient to a family member; provided, however, that any such transfer is without payment of any consideration whatsoever and that no transfer shall be
valid unless first approved by the Committee, acting in its sole discretion. For this purpose, “family member” means any child, stepchild, grandchild, parent, stepparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the employee’s household (other than a tenant or employee), a trust in which the foregoing persons have more than
fifty (50) percent of the beneficial interests, a foundation in which the foregoing persons (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than fifty
(50) percent of the voting interests. 
 7. Specific Terms of Awards 

7.1. Options. 
 (a)
Date of Grant. The granting of an Option shall take place at the time specified in the Award Agreement. Only if expressly so provided in the applicable Award Agreement shall the Grant Date be the date on which the Award
Agreement shall have been duly executed and delivered by the Company and the Optionee. 

  
 4 

 (b) Exercise Price. The price at which shares of Stock may be acquired under each
Incentive Option shall be not less than 100% of the Market Value of Stock on the Grant Date, or not less than 110% of the Market Value of Stock on the Grant Date if the Optionee is a Ten Percent Owner. The price at which shares may be acquired under
each Nonstatutory Option shall not be so limited solely by reason of this Section. 
 (c) Option Period. No Incentive Option
may be exercised on or after the tenth anniversary of the Grant Date, or on or after the fifth anniversary of the Grant Date if the Optionee is a Ten Percent Owner. The Option period under each Nonstatutory Option shall not be so limited solely by
reason of this Section. 
 (d) Exercisability. An Option may be immediately exercisable or become exercisable in such installments,
cumulative or non-cumulative, as the Committee may determine. In the case of an Option not otherwise immediately exercisable in full, the Committee may Accelerate such Option in whole or in part at any time; provided, however, that in the
case of an Incentive Option, any such Acceleration of the Option would not cause the Option to fail to comply with the provisions of Section 422 of the Code or the Optionee consents to the Acceleration. 

(e) Termination of Association with the Company. Unless the Committee shall provide otherwise with
respect to any Option, if the Optionee’s employment or other association with the Company and its Affiliates ends for any reason, including because of the Optionee’s employer ceasing to be an Affiliate, any outstanding Option of the
Optionee shall cease to be exercisable in any respect not later than 90 days following that event and, for the period it remains exercisable following that event, shall be exercisable only to the extent exercisable at the date of that event.
Military or sick leave or other bona fide leave shall not be deemed a termination of employment or other association, provided that it does not exceed the longer of ninety (90) days or the period during which the absent Optionee’s
reemployment rights, if any, are guaranteed by statute or by contract. 
 (f) Method of Exercise. An Option may be
exercised by the Optionee giving written notice, in the manner provided in Section 14, specifying the number of shares with respect to which the Option is then being exercised. The notice shall be accompanied by payment in the form of cash or
check payable to the order of the Company in an amount equal to the exercise price of the shares to be purchased or, subject in each instance to the Committee’s approval, acting in its sole discretion, and to such conditions, if any, as the
Committee may deem necessary to avoid adverse accounting effects to the Company, 
 (i) by delivery to the Company of shares
of Stock having a Market Value equal to the exercise price of the shares to be purchased, or 
 (ii) by surrender of the
Option as to all or part of the shares of Stock for which the Option is then exercisable in exchange for shares of Stock having an aggregate Market Value equal to the difference between (1) the aggregate Market Value of the surrendered
portion of the Option, and (2) the aggregate exercise price under the Option for the surrendered portion of the Option. 
 If the Stock becomes
traded on an established market, payment of any exercise price may also be made through and under the terms and conditions of any formal cashless exercise program authorized by the Company entailing the sale of the Stock subject to an Option in a
brokered transaction (other than to the Company). Receipt by the Company of such notice and payment in any authorized or 

  
 5 

 
combination of authorized means shall constitute the exercise of the Option. Within thirty (30) days thereafter but subject to the remaining provisions of the Plan, the Company shall deliver
or cause to be delivered to the Optionee or his agent a certificate or certificates for the number of shares then being purchased. Such shares shall be fully paid and nonassessable. 

(g) Limit on Incentive Option Characterization. An Incentive Option shall be considered to be an Incentive
Option only to the extent that the number of shares of Stock for which the Option first becomes exercisable in a calendar year do not have an aggregate Market Value (as of the date of the grant of the Option) in excess of the “current
limit”. The current limit for any Optionee for any calendar year shall be $100,000 minus the aggregate Market Value at the date of grant of the number of shares of Stock available for purchase for the first time in the same year under
each other Incentive Option previously granted to the Optionee under the Plan, and under each other incentive stock option previously granted to the Optionee under any other incentive stock option plan of the Company and its Affiliates. Any shares
of Stock which would cause the foregoing limit to be violated shall be deemed to have been granted under a separate Nonstatutory Option, otherwise identical in its terms to those of the Incentive Option. 

(h) Notification of Disposition. Each person exercising any Incentive Option granted under the Plan shall be deemed to
have covenanted with the Company to report to the Company any disposition of such shares prior to the expiration of the holding periods specified by Section 422(a)(1) of the Code and, if and to the extent that the realization of income in such
a disposition imposes upon the Company federal, state, local or other withholding tax requirements, or any such withholding is required to secure for the Company an otherwise available tax deduction, to remit to the Company an amount in cash
sufficient to satisfy those requirements. 
 (i) Rights Pending Exercise. No person holding an Option shall be deemed
for any purpose to be a stockholder of the Company with respect to any of the shares of Stock issuable pursuant to his Option, except to the extent that the Option shall have been exercised with respect thereto and, in addition, a certificate shall
have been issued therefor and delivered to such holder or his agent. 
 7.2. Restricted Stock. 

(a) Purchase Price. Shares of Restricted Stock shall be issued under the Plan for such consideration, in cash, other property or
services, or any combination thereof, as is determined by the Committee. 
 (b) Issuance of Certificates. Each
Participant receiving a Restricted Stock Award, subject to subsection (c) below, shall be issued a stock certificate in respect of such shares of Restricted Stock. Such certificate shall be registered in the name of such Participant, and, if
applicable, shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award substantially in the following form: 

The transferability of this certificate and the shares represented by this certificate are subject to the terms and conditions of Roka
Bioscience, Inc. 2009 Equity Incentive Plan and an Award Agreement entered into by the registered owner and Roka Bioscience, Inc. Copies of such Plan and Agreement are on file in the offices of Roka Bioscience, Inc. 

  
 6 

 (c) Escrow of Shares. The Committee may require that the stock certificates
evidencing shares of Restricted Stock be held in custody by a designated escrow agent (which may but need not be the Company) until the restrictions thereon shall have lapsed, and that the Participant deliver a stock power, endorsed in blank,
relating to the Stock covered by such Award. 
 (d) Restrictions and Restriction Period. During the Restriction
Period applicable to shares of Restricted Stock, such shares shall be subject to limitations on transferability and a Risk of Forfeiture arising on the basis of such conditions related to the performance of services, Company or Affiliate performance
or otherwise as the Committee may determine and provide for in the applicable Award Agreement. Any such Risk of Forfeiture may be waived or terminated, or the Restriction Period shortened, at any time by the Committee on such basis as it deems
appropriate. 
 (e) Rights Pending Lapse of Risk of Forfeiture or Forfeiture
of Award. Except as otherwise provided in the Plan or the applicable Award Agreement, at all times prior to lapse of any Risk of Forfeiture applicable to, or forfeiture of, an Award of Restricted Stock, the Participant shall have all
of the rights of a stockholder of the Company, including the right to vote, and the right to receive any dividends with respect to, the shares of Restricted Stock. The Committee, as determined at the time of Award, may permit or require the payment
of cash dividends to be deferred and, if the Committee so determines, reinvested in additional Restricted Stock to the extent shares are available under Section 4. 

(f) Termination of Association with the Company. Unless the Committee shall provide otherwise for
any Award of Restricted Stock, upon termination of a Participant’s employment or other association with the Company and its Affiliates for any reason during the Restriction Period, including because of the Participant’s employer ceasing to
be an Affiliate during the Restriction Period, all shares of Restricted Stock still subject to Risk of Forfeiture shall be forfeited or otherwise subject to return to or repurchase by the Company on the terms specified in the Award Agreement;
provided, however, that military or sick leave or other bona fide leave shall not be deemed a termination of employment or other association, if it does not exceed the longer of ninety (90) days or the period during which the absent
Participant’s reemployment rights, if any, are guaranteed by statute or by contract. 
 (g) Lapse of Restrictions.
If and when the Restriction Period expires without a prior forfeiture of the Restricted Stock, the certificates for such shares shall be delivered to the Participant promptly if not theretofore so delivered. 

7.3. Stock Grants. Stock Grants shall be awarded solely in recognition of significant contributions to the success of the
Company or its Affiliates, in lieu of compensation otherwise already due and in such other limited circumstances as the Committee deems appropriate. Stock Grants shall be made without forfeiture conditions of any kind. 

7.4. Awards to Participants Outside the United States. The Committee may modify the terms of
any Award under the Plan granted to a Participant who is, at the time of grant or during the term of the Award, resident or primarily employed outside of the United States in any manner deemed by the Committee to be necessary or appropriate in order
that the Award shall conform to laws, regulations, and customs of the country in which the Participant is then resident or primarily employed, or so that the value and other benefits of the Award to the Participant, as affected by foreign tax laws
and other restrictions applicable as a result of the Participant’s 

  
 7 

 
residence or employment abroad, shall be comparable to the value of such an Award to a Participant who is resident or primarily employed in the United States. The Committee may establish
supplements to, or amendments, restatements, or alternative versions of the Plan for the purpose of granting and administrating any such modified Award. No such modification, supplement, amendment, restatement or alternative version may increase the
share limit of Section 4. 
 8. Adjustment and Related Provisions 

8.1. Adjustment for Corporate Actions. All of the share numbers set forth in the Plan reflect the capital structure
of the Company as of September 10, 2009. If subsequent to that date the outstanding shares of Stock (or any other securities covered by the Plan by reason of the prior application of this Section) are increased, decreased, or exchanged for a
different number or kind of shares or other securities, or if additional shares or new or different shares or other securities are distributed with respect to shares of Stock, as a result of a reorganization, recapitalization, reclassification,
stock dividend, stock split, reverse stock split, or other similar distribution with respect to such shares of Stock, an appropriate and proportionate adjustment will be made in (i) the maximum numbers and kinds of shares provided in Section 4,
(ii) the numbers and kinds of shares or other securities subject to the then outstanding Awards, (iii) the exercise price for each share or other unit of any other securities subject to then outstanding Options (without change in the
aggregate purchase price as to which such Options remain exercisable), and (iv) the repurchase price of each share of Restricted Stock then subject to a Risk of Forfeiture in the form of a Company repurchase right. 

8.2. Adjustment of Awards Upon the Occurrence of Certain Unusual or
Nonrecurring Events. In the event of any corporate action not specifically covered by the preceding Section, including but not limited to an extraordinary cash distribution on Stock, a corporate separation or other reorganization or
liquidation, the Committee may make such adjustment of outstanding Awards and their terms, if any, as it, in its sole discretion, may deem equitable and appropriate in the circumstances. 

8.3. Related Matters. Any adjustment in Awards made pursuant to Sections 8.1 or 8.2 shall be determined and made, if at all, by
the Committee acting in its sole discretion and shall include any correlative modification of terms, including of Option exercise prices, rates of vesting or exercisability, Risks of Forfeiture and applicable repurchase prices for Restricted Stock,
which the Committee may deem necessary or appropriate so as to ensure the rights of the Participants in their respective Awards are not substantially diminished nor enlarged as a result of the adjustment and corporate action other than as expressly
contemplated in this Section 8. No fraction of a share shall be purchasable or deliverable upon exercise, but in the event any adjustment hereunder of the number of shares covered by an Award shall cause such number to include a fraction of a
share, such number of shares shall be adjusted to the nearest smaller whole number of shares. No adjustment of an Option exercise price per share pursuant to Sections 8.1 or 8.2 shall result in an exercise price which is less than the par value of
the Stock. 
 8.4. Transactions. 

(a) Definition of Transaction. In this Section 8.4, “Transaction” means (1) any merger or
consolidation of the Company with or into another entity as a result of which the Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (2) any sale or exchange of Stock
of the Company for cash, securities or other property in 

  
 8 

 
a single or series of related transactions if as a result securities possessing more than 50% of the total combined voting power of the survivor’s or acquirer’s outstanding securities
(or the securities of any parent thereof) cease to be held by a person or persons who held securities possessing more than 50% of the total combined voting power of the Company’s outstanding securities immediately prior to that transaction,
(3) any sale, transfer, or other disposition of all or substantially all of the Company’s assets to one or more other persons in a single transaction or series of related transactions or (4) any liquidation or dissolution of the
Company. 
 (b) Treatment of Options. In a Transaction, the Committee may take any one or more of the following actions
as to all or any (or any portion of) outstanding Options. 
 (1) Provide that such Options shall be assumed, or substantially
equivalent options shall be provided in substitution therefore, by the acquiring or succeeding entity (or an affiliate thereof). 

(2) Upon written notice to the holders, provide that the holders’ unexercised Options will terminate immediately prior to
the consummation of such Transaction unless exercised within a specified period following the date of such notice. 
 (3)
Provide that outstanding Options shall become exercisable in whole or in part prior to or upon the Transaction. 
 (4)
Provide for cash payments, net of applicable tax withholdings, to be made to holders equal to the excess, if any, of (A) the acquisition price times the number of shares of Stock subject to an Option (to the extent the exercise price does not
exceed the acquisition price) over (B) the aggregate exercise price for all such shares of Stock subject to the Option, in exchange for the termination of such Option. For this purpose, “acquisition price” means the
amount of cash, and market value of any other consideration, received in payment for a share of Stock surrendered in a Transaction. 

(5) Provide that, in connection with a liquidation or dissolution of the Company, Options shall convert into the right to
receive liquidation proceeds net of the exercise price thereof and any applicable tax withholdings. 
 (6) Any combination of
the foregoing. 
 For purposes of paragraph (1) above, an Option shall be considered assumed, or a substantially equivalent option shall be considered
to have been provided in substitution therefore, if following consummation of the Transaction the Option confers the right to purchase, for each share of Stock subject to the Option immediately prior to the consummation of the Transaction, the
consideration (whether cash, securities or other property) received as a result of the Transaction by holders of Stock for each share of Stock held immediately prior to the consummation of the Transaction (and if holders were offered a choice of
consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Stock); provided, however, that if the consideration received as a result of the Transaction is not solely common stock (or its
equivalent) of the acquiring or succeeding entity (or an affiliate thereof), the Committee 

  
 9 

 
may provide for the consideration to be received upon the exercise of Options to consist solely of common stock (or its equivalent) of the acquiring or succeeding entity (or an affiliate thereof)
equivalent in value to the per share consideration received by holders of outstanding shares of Stock as a result of the Transaction. 
 (c)
Treatment of Restricted Stock. As to outstanding Awards in the form of Restricted Stock, upon the occurrence of a Transaction other than a liquidation or dissolution of the Company which is not part of another form of
Transaction, the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor and shall, unless the Committee determines otherwise, apply to the cash, securities
or other property which the Stock was converted into or exchanged for pursuant to such Transaction in the same manner and to the same extent as they applied to the Restricted Stock Award. Upon the occurrence of a Transaction involving a liquidation
or dissolution of the Company which is not part of another form of Transaction, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock Award or any other agreement between a Participant and the
Company, all Risks of Forfeiture on all Restricted Stock Awards then outstanding shall automatically be deemed terminated or satisfied. 

(d) Related Matters. In taking any of the actions permitted under this Section 8.4, the Committee shall not be obligated to
treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically. Any determinations required to carry out the foregoing provisions of this Section 8.4, including but not limited to the market value of other
consideration received by holders of Stock in a Transaction and whether substantially equivalent options have been substituted, shall be made by the Committee acting in its sole discretion. 

8.5. Changes in Control. Subject to any provisions of then outstanding Awards granting greater rights to the holders
thereof in connection with a Change in Control, in the event of a Change in Control (including a Change of Control which is Transaction), any Restricted Stock Award still then subject to a Risk of Forfeiture and any outstanding Option not then
exercisable in full shall vest under the terms of the Award applied as if the time of reference were (x) six (6) months later than otherwise, with respect to individuals who have been employed by or associated with the Company and its
Affiliates for less than twelve (12) months at the date of the Change in Control, and (y) otherwise, twelve (12) months later than otherwise. For this purpose, “Change of Control” means the occurrence of any of the following
after the date of the approval of the Plan by the Board: 
 (a) any Transaction (as defined in Section 8.4(a) but excluding any
liquidation or dissolution of the Company which is not part of another Transaction), unless securities possessing more than 50% of the total combined voting power of the survivor’s or acquirer’s outstanding securities (or the securities of
any parent thereof) are held by a person or persons who held securities possessing more than 50% of the total combined voting power of the Company’s outstanding securities immediately prior to that transaction, or 

(b) any person or group of persons (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended and in
effect from time to time), directly or indirectly acquires, including but not limited to by means of a merger or consolidation, beneficial ownership (determined pursuant to Securities and Exchange Commission Rule 13d-3 promulgated under the said
Exchange Act) of securities possessing more than 50% of the total combined voting power of the Company’s outstanding securities, other than (i) the Company or an Affiliate, (ii) an employee benefit plan of the Company or any of its
Affiliates, (iii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its Affiliates, or (iv) an underwriter temporarily holding securities pursuant to an offering of such securities.

  
 10 

 9. Settlement of Awards 

9.1. Violation of Law. Notwithstanding any other provision of the Plan or the relevant Award Agreement, if, at any time, in the
reasonable opinion of the Company, the issuance of shares of Stock covered by an Award may constitute a violation of law, then the Company may delay such issuance and the delivery of a certificate for such shares until (i) approval shall have
been obtained from such governmental agencies, other than the Securities and Exchange Commission, as may be required under any applicable law, rule, or regulation and (ii) in the case where such issuance would constitute a violation of a law
administered by or a regulation of the Securities and Exchange Commission, one of the following conditions shall have been satisfied: 
 (a)
the shares are at the time of the issue of such shares effectively registered under the Securities Act of 1933; or 
 (b) the Company shall
have determined, on such basis as it deems appropriate (including an opinion of counsel in form and substance satisfactory to the Company) that the sale, transfer, assignment, pledge, encumbrance or other disposition of such shares or such
beneficial interest, as the case may be, does not require registration under the Securities Act of 1933, as amended or any applicable State securities laws. 

The Company shall make all reasonable efforts to bring about the occurrence of said events. 

9.2. Corporate Restrictions on Rights in Stock. Any Stock to be issued pursuant to Awards granted
under the Plan shall be subject to all restrictions upon the transfer thereof which may be now or hereafter imposed by the charter, certificate or articles, and by-laws, of the Company. Whenever Stock is to be issued pursuant to an Award, if the
Committee so directs at or after grant, the Company shall be under no obligation to issue such shares until such time, if ever, as the recipient of the Award (and any person who exercises any Option, in whole or in part), shall have become a party
to and bound by the Stockholders’ Agreement, if any. In the event of any conflict between the provisions of this Plan and the provisions of the Stockholders’ Agreement, the provisions of the Stockholders’ Agreement shall control
except as required to fulfill the intention that this Plan constitute an incentive stock option plan within the meaning of Section 422 of the Code, but insofar as possible the provisions of the Plan and such Agreement shall be construed so as
to give full force and effect to all such provisions. 
 9.3. Investment Representations. The Company shall be under no
obligation to issue any shares covered by any Award unless the shares to be issued pursuant to Awards granted under the Plan have been effectively registered under the Securities Act of 1933, as amended, or the Participant shall have made such
written representations to the Company (upon which the Company believes it may reasonably rely) as the Company may deem necessary or appropriate for purposes of confirming that the issuance of such shares will be exempt from the registration
requirements of that Act and any applicable state securities laws and otherwise in compliance with all applicable laws, rules and regulations, including but not limited to that the Participant is acquiring the shares for his or her own account for
the purpose of investment and not with a view to, or for sale in connection with, the distribution of any such shares. 

  
 11 

 9.4. Registration. If the Company shall deem it necessary or desirable to register under
the Securities Act of 1933, as amended or other applicable statutes any shares of Stock issued or to be issued pursuant to Awards granted under the Plan, or to qualify any such shares of Stock for exemption from the Securities Act of 1933, as
amended or other applicable statutes, then the Company shall take such action at its own expense. The Company may require from each recipient of an Award, or each holder of shares of Stock acquired pursuant to the Plan, such information in writing
for use in any registration statement, prospectus, preliminary prospectus or offering circular as is reasonably necessary for that purpose and may require reasonable indemnity to the Company and its officers and directors from that holder against
all losses, claims, damage and liabilities arising from use of the information so furnished and caused by any untrue statement of any material fact therein or caused by the omission to state a material fact required to be stated therein or necessary
to make the statements therein not misleading in the light of the circumstances under which they were made. In addition, the Company may require of any such person that he or she agree that, without the prior written consent of the Company or the
managing underwriter in any public offering of shares of Stock, he or she will not sell, make any short sale of, loan, grant any option for the purchase of, pledge or otherwise encumber, or otherwise dispose of, any shares of Stock during the 180
day period commencing on the effective date of the registration statement relating to the underwritten public offering of securities. Without limiting the generality of the foregoing provisions of this Section 9.4, if in connection with any
underwritten public offering of securities of the Company the managing underwriter of such offering requires that the Company’s directors and officers enter into a lock-up agreement containing provisions that are more restrictive than the
provisions set forth in the preceding sentence, then (a) each holder of shares of Stock acquired pursuant to the Plan (regardless of whether such person has complied or complies with the provisions of clause (b) below) shall be bound by,
and shall be deemed to have agreed to, the same lock-up terms as those to which the Company’s directors and officers are required to adhere; and (b) at the request of the Company or such managing underwriter, each such person shall execute
and deliver a lock-up agreement in form and substance equivalent to that which is required to be executed by the Company’s directors and officers. 

9.5. Placement of Legends; Stop Orders; etc. Each share of Stock to be issued pursuant to Awards
granted under the Plan may bear a reference to the investment representation made in accordance with Section 9.3 in addition to any other applicable restriction under the Plan, the terms of the Award and if applicable under the
Stockholders’ Agreement and to the fact that no registration statement has been filed with the Securities and Exchange Commission in respect to such shares of Stock. All certificates for shares of Stock or other securities delivered under the
Plan shall be subject to such stock transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations, and other requirements of any stock exchange upon which the Stock is then listed, and any applicable federal
or state securities law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. 

9.6. Tax Withholding. Whenever shares of Stock are issued or to be issued pursuant to Awards granted under the Plan, the Company
shall have the right to require the recipient to remit to the Company an amount sufficient to satisfy federal, state, local or other withholding tax requirements if, when, and to the extent required by law (whether so required to secure for the
Company an otherwise available tax deduction or otherwise) prior to the delivery of any certificate or certificates for such shares. The obligations of the Company under the Plan shall be conditional on satisfaction of all such withholding
obligations and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the recipient of an 

  
 12 

 
Award. However, in such cases Participants may elect, subject to the approval of the Committee, acting in its sole discretion, to satisfy an applicable withholding requirement, in whole or in
part, by having the Company withhold shares to satisfy their tax obligations. Participants may only elect to have Shares withheld having a Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be
imposed on the transaction. All elections shall be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. 

10. Reservation of Stock 
 The Company
shall at all times during the term of the Plan and any outstanding Options granted hereunder reserve or otherwise keep available such number of shares of Stock as will be sufficient to satisfy the requirements of the Plan (if then in effect) and the
Options and shall pay all fees and expenses necessarily incurred by the Company in connection therewith. 
 11. No Special Employment or Other Rights

 Nothing contained in the Plan or in any Award Agreement shall confer upon any recipient of an Award any right with respect to the
continuation of his or her employment or other association with the Company (or any Affiliate), or interfere in any way with the right of the Company (or any Affiliate), subject to the terms of any separate employment or consulting agreement or
provision of law or corporate charter, certificate or articles, or by-laws, to the contrary, at any time to terminate such employment or consulting agreement or to increase or decrease, or otherwise adjust, the other terms and conditions of the
recipient’s employment or other association with the Company and its Affiliates. 
 12. Nonexclusivity of the Plan 

Neither the adoption of the Plan by the Board nor the submission of the Plan to the stockholders of the Company shall be construed as creating
any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including without limitation, the granting of stock options and restricted stock other than under the Plan, and such arrangements may be
either applicable generally or only in specific cases. 
 13. Termination and Amendment of the Plan 

The Board may at any time terminate the Plan or make such modifications of the Plan as it shall deem advisable. Unless the Board otherwise
expressly provides, no amendment of the Plan shall affect the terms of any Award outstanding on the date of such amendment. 
 The Committee
may amend the terms of any Award theretofore granted, prospectively or retroactively, provided that the Award as amended is consistent with the terms of the Plan. Also within the limitations of the Plan, the Committee may modify, extend or assume
outstanding Awards or may accept the cancellation of outstanding Awards or of outstanding stock options or other equity-based compensation awards granted by another issuer in return for the grant of new Awards for the same or a different number of
shares and on the same or different terms and conditions (including but not limited to the exercise price of any Option). Furthermore, the Committee may at any time (a) offer to buy out for a payment in cash or cash equivalents an Award
previously granted or (b) authorize the recipient of an Award to elect to cash out an Award previously granted, in either case at such time and based upon such terms and conditions as the Committee shall establish. 

  
 13 

 No amendment or modification of the Plan by the Board, or of an outstanding Award by the
Committee, shall impair the rights of the recipient of any Award outstanding on the date of such amendment or modification or such Award, as the case may be, without the Participant’s consent; provided, however, that no such consent
shall be required if (i) the Board or Committee, as the case may be, determines in its sole discretion and prior to the date of any Change of Control (as defined in Section 8.5) that such amendment or alteration either is required or
advisable in order for the Company, the Plan or the Award to satisfy any law or regulation, including without limitation the provisions of Section 409A of the Code, or to meet the requirements of or avoid adverse financial accounting
consequences under any accounting standard, or (ii) the Board or Committee, as the case may be, determines in its sole discretion that such amendment or alteration is not reasonably likely to significantly diminish the benefits provided under
the Award, or that any such diminution has been adequately compensated. 
 14. Notices and Other Communications 

Any notice, demand, request or other communication hereunder to any party shall be deemed to be sufficient if contained in a written instrument
delivered in person or duly sent by first class registered, certified or overnight mail, postage prepaid, or telecopied with a confirmation copy by regular, certified or overnight mail, addressed or telecopied, as the case may be, (i) if to the
recipient of an Award, at his or her residence address last filed with the Company and (ii) if to the Company, at its principal place of business, addressed to the attention of its Treasurer, or to such other address or telecopier number, as
the case may be, as the addressee may have designated by notice to the addressor. All such notices, requests, demands and other communications shall be deemed to have been received: (i) in the case of personal delivery, on the date of such
delivery; (ii) in the case of mailing, when received by the addressee; and (iii) in the case of facsimile transmission, when confirmed by facsimile machine report. 

15. Governing Law 
 The Plan and all Award
Agreements and actions taken thereunder shall be governed, interpreted and enforced in accordance with the laws of the state of Delaware, without regard to the conflict of laws principles thereof. 

  
 14 

 ATTACHMENT A 

Provisions Applicable to Award Recipients 

Resident in California 

Until such time as the Company’s Stock has been effectively registered under the Securities Act and if required by any applicable law,
the following additional terms shall apply to Awards, and Stock issued pursuant to such Awards, granted under the Plan to persons resident in California as of the date of grant of the Award (each such person, a “California
Recipient”). Capitalized terms not defined in this Attachment shall have the respective meanings set forth in the Plan. 
 1. No
Option or other right to acquire Stock pursuant to an Award issued to any California Recipient, that is otherwise transferable pursuant to the terms of the Plan, shall be transferable other than by gift or domestic relations order to an immediate
family member as that term is defined under applicable California and Federal securities law or to a revocable trust (or by will or the laws of descent and distribution). 

2. The following limitations shall apply to the early expiration of Options granted California Recipients on account of termination of
employment (unless employment is terminated for cause as defined by applicable law): 
 (a) Subject to Section 5(b) below, in the event
the employment or other association with the Company and its Affiliates of an Optionee who is a California Resident is terminated, whether voluntary or otherwise and including on account of an entity ceasing to be an Affiliate of the Company, such
California Recipient shall have at least 30 days after the date of such termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to exercise such Option to the extent exercisable as of
the date of such termination. 
 (b) In the event that the employment or association with the Company and its Affiliates of an Optionee who
is a California Resident is terminated as a result of death or disability, such California Recipient shall have at least 6 months after the date of such termination (but in no event later than the expiration of the term of such Option as set forth
in the Award Agreement) to exercise such Option to the extent exercisable as of the date of such termination. 
 3. The Plan must be
approved by a majority of the outstanding securities entitled to vote within 12 months before or after the later of (i) the date the Plan is adopted by the Company and (ii) the date on which any Option or other Award is granted to a
California Recipient. 

  
 15 

 AMENDMENT NO. 1 

TO 
 ROKA BIOSCIENCE, INC.

 2009 EQUITY INCENTIVE PLAN 

This First Amendment (the “Amendment”) to the 2009 Equity Incentive Plan (the “Plan”) of Roka Bioscience,
Inc. (the “Company”) is effective as of April 29, 2011. 
 W I T N E S S E T H: 

WHEREAS, Section 13 of the Plan reserves to the Board of Directors of the Company (the “Board”) the right to
modify the Plan from time to time; 
 WHEREAS, at the June 2010 meeting of the Board, the Board agreed to amend the Plan to increase
the maximum aggregate number of shares that may be issued under the Plan from 5,456,221 to 9,142,857 and the Company’s stockholders approved such amendment; and 

WHEREAS, the Board desires to further amend the Plan in the manner hereinafter provided subject to approval by the Company’s
stockholders. 
 NOW, THEREFORE, the Plan is hereby amended as follows: 

1. Amendment to Section 4. The first sentence of Section 4 of the Plan is hereby amended and restated in its entirety
to read as follows: 
 “At no time shall the number of shares of Stock issued pursuant to or subject to outstanding Awards granted under
the Plan (including pursuant to Incentive Options), nor the number of shares of Stock issued pursuant to Incentive Options, exceed 11,806,564 shares of Stock; subject, however, to the provisions of Section 8 of the Plan.” 

2. Amendment to Section 8.1. The first sentence of Section 8.1 of the Plan is hereby amended and restated in its
entirety to read as follows: 
 “All of the share numbers set forth in the Plan reflect the capital structure of the Company as of
April 29, 2011.” 
 3. Except as set forth herein, the Plan shall remain in full force and effect without modification. 

 IN WITNESS WHEREOF, the undersigned officer hereby certifies that the foregoing amendment
to the Plan was duly adopted and approved by the Board. 
  

							
	Dated: April 29, 2011	 		 	ROKA BIOSCIENCE, INC.
				
		 		 	By: 	 	/s/ Paul Thomas
		 		 	Name:	 	Paul Thomas
		 		 	Title:	 	Chief Executive Officer

 AMENDMENT NO. 2 

TO 
 ROKA BIOSCIENCE, INC.

 2009 EQUITY INCENTIVE PLAN 

This Second Amendment (the “Amendment”) to the 2009 Equity Incentive Plan (the “Plan”) of Roka Bioscience,
Inc. (the “Company”) is effective as of December 19, 2011. 
 W I T N E S S E T H: 

WHEREAS, Section 13 of the Plan reserves to the Board of Directors of the Company (the “Board”) the right to
modify the Plan from time to time; 
 WHEREAS, the Board desires to further amend the Plan in the manner hereinafter provided subject
to approval by the Company’s stockholders. 
 NOW, THEREFORE, the Plan is hereby amended as follows: 

1. Amendment to Section 4. The first sentence of Section 4 of the Plan is hereby amended and restated in its entirety
to read as follows: 
 “At no time shall the number of shares of Stock issued pursuant to or subject to outstanding Awards granted under
the Plan (including pursuant to Incentive Options), nor the number of shares of Stock issued pursuant to Incentive Options, exceed 17,006,564 shares of Stock; subject, however, to the provisions of Section 8 of the Plan.” 

2. Amendment to Section 8.1. The first sentence of Section 8.1 of the Plan is hereby amended and restated in its
entirety to read as follows: 
 “All of the share numbers set forth in the Plan reflect the capital structure of the Company as of
December 19, 2011.” 
 3. Except as set forth herein, the Plan shall remain in full force and effect without modification. 

 IN WITNESS WHEREOF, the undersigned officer hereby certifies that the foregoing amendment
to the Plan was duly adopted and approved by the Board. 
  

							
	Dated: December 19, 2011	 		 	ROKA BIOSCIENCE, INC.
				
		 		 	By:	 	/s/ Paul Thomas
		 		 	Name:	 	Paul Thomas
		 		 	Title:	 	Chief Executive Officer

 AMENDMENT NO. 3 

TO 
 ROKA BIOSCIENCE, INC.

 2009 EQUITY INCENTIVE PLAN 

This Second Amendment (the “Amendment”’) to the 2009 Equity Incentive Plan, as amended (the “Plan”) of
Roka Bioscience, Inc. (the “Company”) is effective as of June 13, 2013. 
 W I T N E S S E T H: 

WHEREAS, Section 13 of the Plan reserves to the Board of Directors of the Company (the “Board”) the right to
modify the Plan from time to time; 
 WHEREAS, the Board desires to further amend the Plan in the manner hereinafter provided subject
to approval by the Company’s stockholders. 
 NOW, THEREFORE, the Plan is hereby amended as follows: 

1. Amendment to Section 4. The first sentence of Section 4 of the Plan is hereby amended and restated in its entirety
to read as follows: 
 “At no time shall the number of shares of Stock issued pursuant to or subject to outstanding Awards granted under
the Plan (including pursuant to Incentive Options), nor the number of shares of Stock issued pursuant to Incentive Options, exceed 22,398,502 shares of Stock; subject, however, to the provisions of Section 8 of the Plan.” 

2. Amendment to Section 8.1. The first sentence of Section 8.1 of the Plan is hereby amended and restated in its
entirety to read as follows: 
 “All of the share numbers set forth in the Plan reflect the capital structure of the Company as of
June 13, 2013.” 
 3. Except as set forth herein, the Plan shall remain in full force and effect without modification. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the undersigned officer hereby certifies that the foregoing amendment
to the Plan was duly adopted and approved by the Board. 
  

							
	Dated: June 13, 2013	 		 	ROKA BIOSCIENCE, INC.
				
		 		 	By:	 	/s/ Paul Thomas
		 		 	Name:	 	Paul Thomas
		 		 	Title:	 	Chief Executive Officer

 AGREEMENT NO. 2012- XX 

ROKA BIOSCIENCE, INC. 

2009 EQUITY INCENTIVE PLAN 

STOCK OPTION AGREEMENT 

THIS AGREEMENT dated as of [        ], 2012,
between Roka Bioscience, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and the individual identified in paragraph 1 below, currently residing at the address set out at the end of this
Agreement (the “Optionee”). 
 1. Grant of Option. Pursuant and subject to the Company’s 2009 Equity Incentive
Plan as attached hereto (as the same may be amended from time to time, the “Plan”), the Company grants to you, the Optionee identified in the table below, an option (the “Option”) to purchase from the Company all or
any part of a total of the number of shares identified in the table below (the “Optioned Shares”) of the common stock, par value $0.001 per share, in the Company (the “Stock”), at the exercise price per share set
out in the table below. 
  

			
	Optionee	  	Name
	 Number of Shares
	  	0
		
	 Exercise Price Per Share
	  	$0.
		
	 Grant Date
	  	Date
		
	 Expiration Date
	  	Date -1 day + 10 yrs

 2. Character of Option. This Option is intended to be treated as an “incentive stock option”
within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended. 
 3. Expiration of Option. This Option
shall expire at 5:00 p.m. Pacific Time on Expiration Date or, if earlier, the earliest of the dates specified in whichever of the following applies: 

(a) If the termination of your employment or other association is on account of your death or disability, the first anniversary of the date
your employment ends. 
 (b) If the termination of your employment or other association is due to any other reason, three (3) months
after your employment or other association ends. 

 (c) If the Company terminates your employment or other association for Cause (as defined below),
or at the termination of your employment or other association the Company had grounds to terminate your employment or other association for Cause (whether then or thereafter determined), immediately upon the termination of your employment or other
association. “Cause” means (i) your willful failure to perform your material job duties, other than a failure resulting from your complete or partial incapacity due to physical or mental illness or impairment, (ii) your
willful act that constitutes gross misconduct and that is injurious to the Company, (iii) your willful breach of a provision of this letter agreement, (iv) your material and willful violation of a federal or state law or regulation
applicable to the business of the Company, or (v) your conviction or plea of guilty or no contest to a felony. 
 4. Exercise of
Option. Until this Option expires or is otherwise terminated in accordance with the Plan, you may exercise it as to the number of Optioned Shares identified in the table below, in full or in part, at any time on or after the applicable exercise
date or dates identified in the table. However, during any period that this Option remains outstanding after your employment or other association with the Company and its Affiliates ends, you may exercise it only to the extent it was exercisable
immediately prior to the end of your employment or other association. The procedure for exercising this Option is described in Section 7.1(f) of the Plan. 
  

			
	 Number of Shares
in Each Installment
	  	 Initial Exercise Date
for Shares in Installment

	 #
	  	[ ]
	 #
	  	 Monthly anniversary of the Grant Date, beginning [ ] and

ending [ ]

	 #
	  	[ ]

 5. Transfer of Option. You may not transfer this Option except by will or the laws of descent and
distribution, and, during your lifetime, only you may exercise this Option. 
 6. Incorporation of Plan Terms. This Option is granted
subject to all of the applicable terms and provisions of the Plan, including but not limited to the limitations on the Company’s obligation to deliver Optioned Shares upon exercise set forth in Section 9 of the Plan (Settlement of
Awards). 
 7. Miscellaneous. This Agreement shall be construed and enforced in accordance with the laws of the State of
Delaware, without regard to the conflict of laws principles thereof and shall be binding upon and inure to the benefit of any successor or assign of the Company and any executor, administrator, trustee, guardian, or other legal representative of
you. Capitalized terms used but not defined herein shall have the meaning assigned under the Plan. This Agreement may be executed in one or more counterparts all of which together shall constitute but one instrument. 

  
 -23- 

 8. Tax Consequences. The Company makes no representation or warranty as to the tax
treatment to you of your receipt or exercise of this Option or upon your sale or other disposition of the Optioned Shares. You should rely on your own tax advisors for such advice. In particular, you acknowledge that in any event this Option will
not be treated as an Incentive Option as to any shares acquired under this Option 
 (a) more than twelve months after your employment ends,
if your employment ends on account of your death or total and permanent disability, or, 
 (b) more than three months after your employment
ends, if your employment ends in any other circumstance. 
 IN WITNESS
WHEREOF, the parties have executed this Agreement as a sealed instrument as of the date first above written. 
  

							
	ROKA BIOSCIENCE, INC.	 		 	OPTIONEE
				
	By:	 	 	 		 	 
		 	Steven Sobieski	 		 	Signature of Optionee
		 	Chief Financial Officer	 		 	
				
		 		 		 	Optionee Address:
		 		 		 	 
		 		 		 	 
		 		 		 	 

  
 -24- 

 AGREEMENT NO. 2012-0XX 

ROKA BIOSCIENCE, INC. 

2009 EQUITY INCENTIVE PLAN 

STOCK OPTION AGREEMENT 

THIS AGREEMENT dated as of [        ], 2012
between Roka Bioscience, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and the individual identified in paragraph 1 below, currently residing at the address set out at the end of this
Agreement (the “Optionee”). 
 1. Grant of Option. Pursuant and subject to the Company’s 2009 Equity Incentive
Plan as attached hereto (as the same may be amended from time to time, the “Plan”), the Company grants to you, the Optionee identified in the table below, an option (the “Option”) to purchase from the Company all or
any part of a total of the number of shares identified in the table below (the “Optioned Shares”) of the common stock, par value $0.001 per share, in the Company (the “Stock”), at the exercise price per share set
out in the table below. 
  

			
	Optionee	  	Name
	 Number of Shares
	  	0
		
	 Exercise Price Per Share
	  	$0.XX
		
	 Grant Date
	  	Date
		
	 Expiration Date
	  	Date –1 day + 10 years

 2. Character of Option. This Option is intended to be treated as an “incentive stock option”
within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended. 
 3. Expiration of Option. This Option
shall expire at 5:00 p.m. Pacific Time on Expiration Date or, if earlier, the earliest of the dates specified in whichever of the following applies: 

(a) If the termination of your employment or other association is on account of your death or disability, the first anniversary of the date
your employment ends. 
 (b) If the termination of your employment or other association is due to any other reason, three (3) months
after your employment or other association ends. 

 (c) If the Company terminates your employment or other association for Cause (as defined below),
or at the termination of your employment or other association the Company had grounds to terminate your employment or other association for Cause (whether then or thereafter determined), immediately upon the termination of your employment or other
association. 
 4. Exercise of Option. 

(a) Until this Option expires or is otherwise terminated in accordance with the Plan, you may exercise it as to the number of Optioned Shares
identified in the table below, in full or in part, at any time on or after the applicable exercise date or dates identified in the table. However, during any period that this Option remains outstanding after your employment or other association with
the Company and its Affiliates ends, you may exercise it only to the extent it was exercisable immediately prior to the end of your employment or other association. The procedure for exercising this Option is described in Section 7.1(f) of the
Plan. 
  

			
	 Number of Shares
in Each Installment
	  	 Initial Exercise Date
for Shares in Installment

	 0
	  	[   1st anniversary of Grant]
	 0
	  	Monthly anniversary of the Grant Date, beginning [   ] and ending [   ]
	 0
	  	[   ]

 (b) If your employment with the Company is terminated by you for Good Reason at any time after [ 1st anniversary of grant] and before the Option is fully exercisable pursuant to Section 4(a), that portion of the Optioned Shares that remain unvested shall accelerate and vest on the date of such
termination. “Good Reason” means, unless you give prior written consent, (i) a decrease in base salary, unless the Company is proportionately reducing the base salary of all of its other executive employees, or
(ii) Company relocation over 50 miles from its office location on the Grant Date; provided that if you terminate your employment with the Company on a date that is more than 30 days following the occurrence of an event described in clause
(i) or (ii) of this paragraph (b), you shall not be deemed to have terminated your employment for Good Reason. 
 (c) If a
Corporate Reorganization occurs before the Option is fully exercisable pursuant to Section 4(a), the unvested portion of the Option shall accelerate and vest in full on the first anniversary of such Corporate Reorganization; provided
that if, prior to the first anniversary of such Corporate Reorganization, your employment with the Company (or any successor to, or affiliate of, the Company) is terminated by the Company (or any successor to, or affiliate of, the Company) other
than for Cause, the unvested portion of the Option shall accelerate and vest in full on the date of such termination. “Corporate Reorganization” shall have the meaning ascribed to such term in the Company’s Amended and Restated
Certificate of Incorporation (as the same may be amended from time to time). “Cause” means (i) your willful failure to perform your material job duties, other than a failure resulting from your complete

  
 -26- 

 
or partial incapacity due to physical or mental illness or impairment, (ii) your willful act that constitutes gross misconduct and that is injurious to the Company, (iii) your willful
breach of a provision of this letter agreement, (iv) your material and willful violation of a federal or state law or regulation applicable to the business of the Company, or (v) your conviction or plea of guilty or no contest to a felony.

 5. Transfer of Option. You may not transfer this Option except by will or the laws of descent and distribution, and, during your
lifetime, only you may exercise this Option. 
 6. Incorporation of Plan Terms. This Option is granted subject to all of the
applicable terms and provisions of the Plan, including but not limited to the limitations on the Company’s obligation to deliver Optioned Shares upon exercise set forth in Section 9 (Settlement of Awards). 

7. Miscellaneous. This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without regard
to the conflict of laws principles thereof and shall be binding upon and inure to the benefit of any successor or assign of the Company and any executor, administrator, trustee, guardian, or other legal representative of you. Capitalized terms used
but not defined herein shall have the meaning assigned under the Plan. This Agreement may be executed in one or more counterparts all of which together shall constitute but one instrument. 

8. Tax Consequences. The Company makes no representation or warranty as to the tax treatment to you of your receipt or exercise of this
Option or upon your sale or other disposition of the Optioned Shares. You should rely on your own tax advisors for such advice. In particular, you acknowledge that in any event this Option will not be treated as an Incentive Option as to any shares
acquired under this Option 
 (a) more than twelve months after your employment ends, if your employment ends on account of your death or
total and permanent disability, or, 
 (b) more than three months after your employment ends, if your employment ends in any other
circumstance. 

  
 -27- 

 IN WITNESS WHEREOF, the
parties have executed this Agreement as a sealed instrument as of the date first above written. 
  

							
	ROKA BIOSCIENCE, INC.	 		 	
				
	By:	 	 	 		 	 
		 	Steven Sobieski	 		 	Signature of Optionee
		 	Chief Financial Officer	 		 	
				
		 		 		 	Optionee Address:
		 		 		 	 
		 		 		 	 
		 		 		 	 

  
 -28- 

 RESTRICTED STOCK AGREEMENT 

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made as of the      day of
            , 2013 (the “Effective Date”), by and between Roka Bioscience, Inc., a Delaware corporation (the “Company”) and [•] (the
“Participant”). 
 WHEREAS, the Company maintains the Roka Bioscience, Inc. 2009 Equity Incentive Plan (the
“Plan”); 
 WHEREAS, the Plan permits the grant of shares of Stock of the Company, subject to certain restrictions; and

 WHEREAS, the Company desires to award the Participant the number of shares of Stock indicated below, subject to the restrictions, terms
and conditions contained in the Plan and this Agreement. 
 NOW, THEREFORE, in consideration of these premises and the agreements set forth
herein, the parties, intending to be legally bound hereby, agree as follows: 
 1. Award of Restricted Stock. Pursuant to the Plan,
the Company hereby awards the Participant [•] shares of Stock (the “Restricted Stock”), subject to the restrictions, terms and conditions set forth in this Agreement and the Plan. The purchase price of the shares of
Restricted Stock shall be $0. 
 2. Vesting. The shares of Restricted Stock will vest, and cease to be Restricted Stock hereunder, in
accordance with this Section 2. 
 (a) Performance-Based Vesting. Except as otherwise provided in this
Section 2, one-hundred percent (100%) of the Restricted Stock shall vest as of the date the Fair Market Value (as defined below) per share of Stock is no less than $2.55, with such dollar value subject to such adjustments
upon a Corporate Event (as defined below) as the Committee deems equitable and appropriate, in its sole discretion. Whether any of the Restricted Stock has vested in accordance with this Section 2(b) shall be determined by the Committee
in its sole discretion. 
 For purposes of this Agreement, the “Fair Market Value” of a share of Stock shall mean, as applied to a specific
date, (i) the closing price of a share of Stock on the principal established stock exchange or national market system on which the Stock is then traded, or (ii) if the shares of Stock are not then traded on an established stock exchange or
national market system but are then traded in an over-the-counter market, the average of the closing bid and asked prices for the shares of Stock in such over-the-counter market, or (iii) if the shares of Stock are not then listed on a national
securities exchange or national market system or traded in an over-the-counter market, the price of a share of Stock established in an equity financing consummated after the Effective Date and prior to the consummation of an initial public offering
of the Company’s Stock. 
 For purposes of this Agreement, “Corporate Event” shall mean any recapitalization, reclassification, stock
dividend, extraordinary dividend, stock split, reverse stock split, or other distribution with respect to the shares of Stock, or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any other change
affecting the Stock. 

 (b) Vesting Upon Termination Without Cause or for Good Reason. If the Participant’s
employment or other service with the Company is terminated (i) by the Company without Cause or (ii) by the Participant for Good Reason at any time after the Effective Date and before the Restricted Stock is fully vested pursuant to this
Section 2, all restrictions applicable to the Restricted Stock shall lapse, and all of the Restricted Stock shall fully and immediately vest, on the date of such termination. For purposes of this Agreement,
(i) “Cause” means (x) the Participant’s willful failure to perform the Participant’s material job duties, other than a failure resulting from the Participant’s complete or partial incapacity due to physical
or mental illness or impairment, (y) the Participant’s willful act that constitutes gross misconduct and that is injurious to the Company, (z) the Participant’s willful breach of a provision of this letter agreement,
(xx) the Participant’s material and willful violation of a federal or state law or regulation applicable to the business of the Company, or (yy) the Participant’s conviction or plea of guilty or no contest to a felony, and (ii) a
termination by the Participant shall be for “Good Reason” if the Participant terminates employment or other service within 30 days following the occurrence, without the prior written consent of the Participant, of (x) a
decrease in base salary, unless the Company is proportionately reducing the base salary of all of its other executive employees, as determined by the Committee in its sole discretion, or (y) relocation of the Participant’s principal place
of employment or other service over 50 miles from its location on the Effective Date. 
 (c) Vesting Upon Corporate Reorganization.
If a Corporate Reorganization occurs before the Restricted Stock is fully vested pursuant to this Section 2, all restrictions applicable to the Restricted Stock shall lapse, and all of the Restricted Stock shall fully and immediately
vest, on the first anniversary of such Corporate Reorganization; provided that if, prior to the first anniversary of such Corporate Reorganization, the Participant’s employment or other service with the Company (or any successor to, or
affiliate of, the Company) is terminated (i) by the Company (or any successor to, or affiliate of, the Company) other than for Cause, or (ii) by the Participant for Good Reason, the unvested shares of Restricted Stock shall vest in full on
the date of such termination. For purposes of this Agreement, “Corporate Reorganization” shall have the meaning ascribed to such term in the Company’s Amended and Restated Certificate of Incorporation (as the same may be
amended from time to time). 
 (d) All Unvested Shares Forfeited Upon Termination of Service Relationship. Except as otherwise
provided in this Section 2, upon termination of the Participant’s employment or other service with the Company and its Affiliates for any reason: (i) any shares of Restricted Stock that have not, on or prior to the date of such
termination, become vested will immediately and automatically, without any action on the part of the Company, be forfeited and returned to the Company, without payment therefore by the Company, and (ii) the Participant will have no further
rights with respect to those shares. A military or sick leave or other bona fide leave shall not be deemed a termination of employment or other service, if it does not exceed the longer of (i) ninety (90) days or (ii) the period
during which Participant’s reemployment rights, if any, are guaranteed by statute or by contract. 

  
 -30- 

 3. Certificated Shares. The shares of Restricted Stock shall be issued in the form of
certificated shares. The following legend will be placed on the certificate (in addition to any other legends that may be required to be placed on such certificates pursuant to the Plan, applicable law or otherwise): 

THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE ROKA
BIOSCIENCE, INC. 2009 EQUITY INCENTIVE PLAN AND AN AWARD AGREEMENT ENTERED INTO BY THE REGISTERED OWNER AND ROKA BIOSCIENCE, INC. COPIES OF SUCH PLAN AND AGREEMENT ARE ON FILE IN THE OFFICES OF ROKA BIOSCIENCE, INC. 

If a certificate representing the shares of Restricted Stock is registered in the name of the Participant, the Company shall retain physical possession of the
certificate while the shares of Restricted Stock remain unvested and the Participant shall be required to deliver a stock power to the Company, endorsed in blank, relating to the shares of Restricted Stock. 

4. Restriction on Transfer of Unvested Shares. Except for the forfeiture of Restricted Stock to the Company in accordance herewith or
the Plan, the Participant may not sell, pledge, assign, encumber, hypothecate, gift, transfer, bequeath, devise, donate or otherwise dispose of, in any way or manner whatsoever, whether voluntary or involuntary, any legal or beneficial interest in
any of the Restricted Stock while the shares of Restricted Stock remain unvested. After any of shares of Restricted Stock vest pursuant to this Agreement, such shares will remain subject to the terms of the Plan. 

5. Capital Changes. If, while any of the shares of Restricted Stock remain unvested, there occurs any merger, consolidation,
reorganization, reclassification, recapitalization, stock split, stock dividend, or other similar change in the Stock, then any and all new, substituted or additional securities or other consideration to which the Participant is entitled by reason
of the Participant’s ownership of the Restricted Stock will thereafter be included in the term “Restricted Stock” for all purposes of the Plan and this Agreement. 

6. Tax Consequences. CERTAIN FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE GRANT AND VESTING OF THE RESTRICTED STOCK, AS OF
THE EFFECTIVE DATE, ARE SUMMARIZED BELOW. THE FOLLOWING DESCRIPTION OF FEDERAL INCOME TAX CONSEQUENCES IS NECESSARILY INCOMPLETE (AS THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE). MOREOVER, THIS SUMMARY ONLY ADDRESSES THE FEDERAL INCOME TAX
CONSEQUENCES UNDER THE LAWS OF THE UNITED STATES, AND DOES NOT ADDRESS WHETHER AND HOW THE TAX LAWS OF ANY OTHER JURISDICTION MAY APPLY TO THE RESTRICTED STOCK OR TO THE PARTICIPANT. ACCORDINGLY, THE PARTICIPANT SHOULD CONSULT A TAX ADVISER
REGARDING THE FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 
 The Participant may file an
election (an “Election”) with the Internal Revenue Service (“IRS”), within 30 days of the issuance of the Restricted Stock, electing pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended
(the “Code”), to be taxed currently on any difference between the fair market value of the Restricted Stock and the purchase price of the Restricted Stock 

  
 -31- 

 
on the date of grant. Absent such an election, taxable income will be measured and recognized by the Participant at the time or times at which the forfeiture restrictions on the Restricted Stock
lapses. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. If the Participant files an Election under Section 83(b) of the Code with the IRS, the Participant agrees to promptly furnish a copy of
such Election to the Company. 
 7. Additional Documents. As a condition to the receipt of the shares of Restricted Stock granted
hereby: 
 (a) If requested by the Company, the Participant shall execute and become a party to such agreements as the Company requires,
which may include, without limitation, the Company’s Fourth Amended and Restated Investor Rights Agreement, Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement, and/or Fourth Amended and Restated Voting Agreement; and 

(b) the Participant agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or
intent of this Agreement. 
 8. Vested Shares Remain Subject to Plan. Notwithstanding the vesting of any shares of Restricted Stock
pursuant to Section 2, the Participant acknowledges and agrees that, in addition to the restrictions set forth herein, the shares will remain subject to the terms and conditions of the Plan. 

9. Representations and Warranties. By executing this Agreement, the Participant hereby represents, warrants, covenants, acknowledges
and/or agrees that: 
 (a) The Restricted Stock is being acquired for the Participant’s own account, for investment purposes only, and
not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”); 

(b) No other person (other than the Participant, his spouse and the Company) has or will have a direct or indirect beneficial interest in the
Restricted Stock; 
 (c) The Restricted Stock has not been registered or qualified under the Securities Act or any state securities laws;

 (d) There is no public market for the Restricted Stock, there can be no assurance that any such market will ever develop and, therefore,
the Participant may be required to hold the Restricted Stock indefinitely; 
 (e) In addition to complying with other similar restrictions
contained herein, the Participant will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Stock unless such interest is registered in accordance with the Securities Act and applicable state securities laws
or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is not required; and 

  
 -32- 

 (f) The Company is under no obligation to register the Restricted Stock on behalf of the
Participant or to assist the Participant in complying with any exemption from registration. 
  

	10.	General Provisions. 

 (a) The Participant agrees to be bound by the terms and conditions
of the Plan, which are incorporated herein by reference and which control in case of any conflict with this Agreement. 
 (b) Capitalized
terms used but not defined herein will have the same meaning as defined in the Plan. 
 (c) This Agreement, together with the Plan,
represents the entire agreement between the parties and supersedes any prior agreement, written or otherwise, relating to the subject matter hereof. This Agreement may not be amended except by written instrument signed by each of the parties hereto.

 (d) Any notice required or permitted to be given by either the Company or the Participant pursuant to the terms of this Agreement shall
be in writing and shall be deemed given on the date and at the time delivered via personal, courier or recognized overnight delivery service or, if sent via telecopier, on the date and at the time telecopied with confirmation of delivery or, if
mailed, on the date five (5) days after the date of the mailing (which shall be by regular, registered or certified mail). Delivery of a notice by telecopy (with confirmation) shall be permitted and shall be considered delivery of a notice
notwithstanding that it is not an original that is received. If directed to the Participant, any such notice shall be sent to the address on file with the Company, or to such other address as the Participant may hereafter specify in writing. If
directed to the Company, any such notice shall be sent to the Company’s principal executive office, c/o the Company’s Secretary, or to such other address or person as the Company may hereafter specify in writing. 

(e) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Participant, his beneficiaries or legal
representatives, and any purported assignment in violation hereof shall be null and void. 
 (f) Either party’s failure to enforce any
provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both
parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances. 

(g) The grant of Restricted Stock hereunder will not confer upon the Participant any right to continue in the employment or other service of
the Company or any of its Affiliates. 
 (h) This Agreement shall be governed by and construed in accordance with the laws and judicial
decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws of Delaware or any other jurisdiction. 

  
 -33- 

 (i) This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original, and all of which together shall be deemed to be one and the same instrument. 
 [Signature Page Follows] 

  
 -34- 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first written
above. 
  

			
	ROKA BIOSCIENCE, INC.
		
	By:	 	 
		 	Name:
		 	Title:

 
			
	
	[PARTICIPANT]
	
	 

  
 -35- 

 EXHIBIT A 

ELECTION UNDER SECTION 83(b) 

OF THE INTERNAL REVENUE CODE OF 1986 

The undersigned taxpayer hereby makes an election pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, and the
Treasury Regulations thereunder (the “Regulations”), and in connection with this election supplies the following information: 
 1.
The name, address and taxpayer identification number of the undersigned are: 
 [Name] 

[Address] 
 Social Security
Number:              -              -
             
 2. The election is being made with respect to [•] shares of
common stock (the “Stock”) of Roka Bioscience, Inc., a Delaware corporation (the “Company”). 
 3. The date on which the Stock was
transferred to the undersigned was [                    ]. The taxable year for which this election is being made is calendar year
[            ]. 
 4. The property is subject to the following restrictions: 

The above-mentioned shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the
Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. 
 Disposition of the Stock is
also subject to restrictions imposed under applicable federal and state securities laws regulating the transfer of unregistered securities. 
 5. The fair
market value of the Stock at the time of transfer (determined without regard to any lapse restriction, as defined in §1.83-3(i) of the Regulations) was $[•]. 

6. The undersigned did not pay any amount for the Stock. Therefore, $[•] (the full fair market value of the Stock stated above) is includible in
the undersigned’s gross income as compensation for services. 
 7. A copy of this election has been furnished to the Company [and to the transferee of
the Stock, if different from the taxpayer] as required by §1.83-2(d) of the Regulations. 
  

					
			
	Dated:                     	 		 	   

		 		 	[taxpayer signature]

 INSTRUCTIONS FOR FILING SECTION 83(B) ELECTION 

Attached is a form of election under section 83(b) of the Internal Revenue Code. If you wish to make such an election, you should complete,
sign and date the election and then proceed as follows: 
 1. Execute three counterparts of your completed election (plus one extra counterpart for each
person other than you, if any who receives property that is the subject of your election), retaining at least one photocopy for your records. 
 2. Send one
counterpart to the Internal Revenue Service Center with which you will file your Federal income tax return for the current year via certified mail, return receipt requested. THE ELECTION SHOULD BE SENT IMMEDIATELY, AS YOU ONLY HAVE 30 DAYS FROM THE
ISSUANCE/PURCHASE/GRANT DATE WITHIN WHICH TO MAKE THE ELECTION – NO WAIVERS, LATE FILINGS OR EXTENSIONS ARE PERMITTED. 
 3. Deliver one counterpart of
the completed election to the Company for its files. 
 4. If anyone other than you (e.g., one of your family members) will receive property that is the
subject of your election, deliver one counterpart of the completed election to each such person. 
 5. Attach one counterpart of the completed election to
your Federal income tax return for this year when you file that return next year. 

  
 -37- 

 RESTRICTED STOCK AGREEMENT 

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made as of the
            day of             , 2013 (the “Effective Date”), by and between Roka Bioscience,
Inc., a Delaware corporation (the “Company”) and [•] (the “Participant”). 
 WHEREAS, the Company
maintains the Roka Bioscience, Inc. 2009 Equity Incentive Plan (the “Plan”); 
 WHEREAS, the Plan permits the grant of
shares of Stock of the Company, subject to certain restrictions; and 
 WHEREAS, the Company desires to award the Participant the number of
shares of Stock indicated below, subject to the restrictions, terms and conditions contained in the Plan and this Agreement. 
 NOW,
THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows: 

1. Award of Restricted Stock. Pursuant to the Plan, the Company hereby awards the Participant [•] shares of Stock (the
“Restricted Stock”), subject to the restrictions, terms and conditions set forth in this Agreement and the Plan. The purchase price of the shares of Restricted Stock shall be $0. 

2. Vesting. The shares of Restricted Stock will vest, and cease to be Restricted Stock hereunder, in accordance with this
Section 2. 
 (a) Performance-Based Vesting. Except as otherwise provided in this Section 2, one-hundred
percent (100%) of the Restricted Stock shall vest as of the date the Fair Market Value (as defined below) per share of Stock is no less than $2.55, with such dollar value subject to such adjustments upon a Corporate Event (as defined
below) as the Committee deems equitable and appropriate, in its sole discretion. Whether any of the Restricted Stock has vested in accordance with this Section 2(b) shall be determined by the Committee in its sole discretion. 

For purposes of this Agreement, the “Fair Market Value” of a share of Stock shall mean, as applied to a specific date, (i) the closing price of
a share of Stock on the principal established stock exchange or national market system on which the Stock is then traded, or (ii) if the shares of Stock are not then traded on an established stock exchange or national market system but are then
traded in an over-the-counter market, the average of the closing bid and asked prices for the shares of Stock in such over-the-counter market, or (iii) if the shares of Stock are not then listed on a national securities exchange or national
market system or traded in an over-the-counter market, the price of a share of Stock established in an equity financing consummated after the Effective Date and prior to the consummation of an initial public offering of the Company’s Stock.

 For purposes of this Agreement, “Corporate Event” shall mean any recapitalization, reclassification, stock dividend, extraordinary dividend,
stock split, reverse stock split, or other distribution with respect to the shares of Stock, or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any other change affecting the Stock. 

 (b) Accelerated Vesting Upon Certain Events. All restrictions applicable to the Restricted
Stock granted pursuant to this Agreement shall lapse, and all of the Restricted Stock shall fully and immediately vest, on the date of (i) a Change in Control (as such term is defined in the Employment Agreement between the Participant and the
Company dated September 10, 2009 (the “Employment Agreement”)) or (ii) a termination of the Participant’s employment or other service by the Company without Cause (as defined in Section 4.01(C) of the Employment
Agreement) or by him for Good Reason (as defined in Section 4.01(E) of the Employment Agreement). 
 (c) All Unvested Shares
Forfeited Upon Termination of Service Relationship. Except as otherwise provided in Section 2(b), upon termination of the Participant’s employment or other service with the Company and its Affiliates for any reason: (i) any
shares of Restricted Stock that have not, on or prior to the date of such termination, become vested will immediately and automatically, without any action on the part of the Company, be forfeited and returned to the Company, without payment
therefore by the Company, and (ii) the Participant will have no further rights with respect to those shares. A military or sick leave or other bona fide leave shall not be deemed a termination of employment or other service, if it does not
exceed the longer of (i) ninety (90) days or (ii) the period during which Participant’s reemployment rights, if any, are guaranteed by statute or by contract. 

3. Certificated Shares. The shares of Restricted Stock shall be issued in the form of certificated shares. The following legend will be
placed on the certificate (in addition to any other legends that may be required to be placed on such certificates pursuant to the Plan, applicable law or otherwise): 

THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE ROKA
BIOSCIENCE, INC. 2009 EQUITY INCENTIVE PLAN AND AN AWARD AGREEMENT ENTERED INTO BY THE REGISTERED OWNER AND ROKA BIOSCIENCE, INC. COPIES OF SUCH PLAN AND AGREEMENT ARE ON FILE IN THE OFFICES OF ROKA BIOSCIENCE, INC. 

If a certificate representing the shares of Restricted Stock is registered in the name of the Participant, the Company shall retain physical possession of the
certificate while the shares of Restricted Stock remain unvested and the Participant shall be required to deliver a stock power to the Company, endorsed in blank, relating to the shares of Restricted Stock. 

4. Restriction on Transfer of Unvested Shares. Except for the forfeiture of Restricted Stock to the Company in accordance herewith or
the Plan, the Participant may not sell, pledge, assign, encumber, hypothecate, gift, transfer, bequeath, devise, donate or otherwise dispose of, in any way or manner whatsoever, whether voluntary or involuntary, any legal or beneficial interest in
any of the Restricted Stock while the shares of Restricted Stock remain unvested. After any of shares of Restricted Stock vest pursuant to this Agreement, such shares will remain subject to the terms of the Plan. 

  
 -39- 

 5. Capital Changes. If, while any of the shares of Restricted Stock remain unvested, there
occurs any merger, consolidation, reorganization, reclassification, recapitalization, stock split, stock dividend, or other similar change in the Stock, then any and all new, substituted or additional securities or other consideration to which the
Participant is entitled by reason of the Participant’s ownership of the Restricted Stock will thereafter be included in the term “Restricted Stock” for all purposes of the Plan and this Agreement. 

6. Tax Consequences. CERTAIN FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE GRANT AND VESTING OF THE RESTRICTED STOCK, AS OF
THE EFFECTIVE DATE, ARE SUMMARIZED BELOW. THE FOLLOWING DESCRIPTION OF FEDERAL INCOME TAX CONSEQUENCES IS NECESSARILY INCOMPLETE (AS THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE). MOREOVER, THIS SUMMARY ONLY ADDRESSES THE FEDERAL INCOME TAX
CONSEQUENCES UNDER THE LAWS OF THE UNITED STATES, AND DOES NOT ADDRESS WHETHER AND HOW THE TAX LAWS OF ANY OTHER JURISDICTION MAY APPLY TO THE RESTRICTED STOCK OR TO THE PARTICIPANT. ACCORDINGLY, THE PARTICIPANT SHOULD CONSULT A TAX ADVISER
REGARDING THE FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 
 The Participant may file an
election (an “Election”) with the Internal Revenue Service (“IRS”), within 30 days of the issuance of the Restricted Stock, electing pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended
(the “Code”), to be taxed currently on any difference between the fair market value of the Restricted Stock and the purchase price of the Restricted Stock on the date of grant. Absent such an election, taxable income will be
measured and recognized by the Participant at the time or times at which the forfeiture restrictions on the Restricted Stock lapses. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. If the Participant
files an Election under Section 83(b) of the Code with the IRS, the Participant agrees to promptly furnish a copy of such Election to the Company. 

7. Additional Documents. As a condition to the receipt of the shares of Restricted Stock granted hereby: 

(a) If requested by the Company, the Participant shall execute and become a party to such agreements as the Company requires, which may
include, without limitation, the Company’s Fourth Amended and Restated Investor Rights Agreement, Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement, and/or Fourth Amended and Restated Voting Agreement; and 

(b) the Participant agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or
intent of this Agreement. 
 8. Vested Shares Remain Subject to Plan. Notwithstanding the vesting of any shares of Restricted Stock
pursuant to Section 2, the Participant acknowledges and agrees that, in addition to the restrictions set forth herein, the shares will remain subject to the terms and conditions of the Plan. 

  
 -40- 

 9. Representations and Warranties. By executing this Agreement, the Participant hereby
represents, warrants, covenants, acknowledges and/or agrees that: 
 (a) The Restricted Stock is being acquired for the Participant’s
own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”); 

(b) No other person (other than the Participant, his spouse and the Company) has or will have a direct or indirect beneficial interest in the
Restricted Stock; 
 (c) The Restricted Stock has not been registered or qualified under the Securities Act or any state securities laws;

 (d) There is no public market for the Restricted Stock, there can be no assurance that any such market will ever develop and, therefore,
the Participant may be required to hold the Restricted Stock indefinitely; 
 (e) In addition to complying with other similar restrictions
contained herein, the Participant will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Stock unless such interest is registered in accordance with the Securities Act and applicable state securities laws
or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is not required; and 

(f) The Company is under no obligation to register the Restricted Stock on behalf of the Participant or to assist the Participant in complying
with any exemption from registration. 
 10. General Provisions. 

(a) The Participant agrees to be bound by the terms and conditions of the Plan, which are incorporated herein by reference and which control
in case of any conflict with this Agreement. 
 (b) Capitalized terms used but not defined herein will have the same meaning as defined in
the Plan. 
 (c) This Agreement, together with the Plan, represents the entire agreement between the parties and supersedes any prior
agreement, written or otherwise, relating to the subject matter hereof. This Agreement may not be amended except by written instrument signed by each of the parties hereto. 

(d) Any notice required or permitted to be given by either the Company or the Participant pursuant to the terms of this Agreement shall be in
writing and shall be deemed given on the date and at the time delivered via personal, courier or recognized overnight delivery service or, if sent via telecopier, on the date and at the time telecopied with confirmation of delivery or, if mailed, on
the date five (5) days after the date of the mailing (which shall be by regular, registered or certified mail). Delivery of a notice by telecopy (with confirmation) shall be permitted and shall be considered delivery of a notice notwithstanding
that it is not an original 

  
 -41- 

 
that is received. If directed to the Participant, any such notice shall be sent to the address on file with the Company, or to such other address as the Participant may hereafter specify in
writing. If directed to the Company, any such notice shall be sent to the Company’s principal executive office, c/o the Company’s Secretary, or to such other address or person as the Company may hereafter specify in writing. 

(e) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Participant, his beneficiaries or legal
representatives, and any purported assignment in violation hereof shall be null and void. 
 (f) Either party’s failure to enforce any
provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both
parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances. 

(g) The grant of Restricted Stock hereunder will not confer upon the Participant any right to continue in the employment or other service of
the Company or any of its Affiliates. 
 (h) This Agreement shall be governed by and construed in accordance with the laws and judicial
decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws of Delaware or any other jurisdiction. 

(i) This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall be
deemed to be one and the same instrument. 

  
 -42- 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first written
above. 
  

			
	ROKA BIOSCIENCE, INC.
		
	By:	 	 
		 	 Name:
 Title:

  

	
	[PARTICIPANT]
	   

  
 -43- 

 EXHIBIT A 

ELECTION UNDER SECTION 83(b) 

OF THE INTERNAL REVENUE CODE OF 1986 

The undersigned taxpayer hereby makes an election pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, and the
Treasury Regulations thereunder (the “Regulations”), and in connection with this election supplies the following information: 
  

	1.	The name, address and taxpayer identification number of the undersigned are: 

[Name] 

[Address] 

Social Security Number:
        -__-             
 2. The
election is being made with respect to [•] shares of common stock (the “Stock”) of Roka Bioscience, Inc., a Delaware corporation (the “Company”). 

3. The date on which the Stock was transferred to the undersigned was
[                    ]. The taxable year for which this election is being made is calendar year
[        ]. 
 4. The property is subject to the following restrictions: 

The above-mentioned shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the
Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. 
 Disposition of the Stock is
also subject to restrictions imposed under applicable federal and state securities laws regulating the transfer of unregistered securities. 
 5. The fair
market value of the Stock at the time of transfer (determined without regard to any lapse restriction, as defined in §1.83-3(i) of the Regulations) was $[•]. 

6. The undersigned did not pay any amount for the Stock. Therefore, $[•] (the full fair market value of the Stock stated above) is includible in
the undersigned’s gross income as compensation for services. 
 7. A copy of this election has been furnished to the Company [and to the transferee of
the Stock, if different from the taxpayer] as required by §1.83-2(d) of the Regulations. 
  

							
				
	Dated:
                                         
           	 		 		 	 
		 		 		 	[taxpayer signature]

 INSTRUCTIONS FOR FILING SECTION 83(B) ELECTION 

Attached is a form of election under section 83(b) of the Internal Revenue Code. If you wish to make such an election, you should complete,
sign and date the election and then proceed as follows: 
 1. Execute three counterparts of your completed election (plus one extra counterpart for each
person other than you, if any who receives property that is the subject of your election), retaining at least one photocopy for your records. 
 2. Send one
counterpart to the Internal Revenue Service Center with which you will file your Federal income tax return for the current year via certified mail, return receipt requested. THE ELECTION SHOULD BE SENT IMMEDIATELY, AS YOU ONLY HAVE 30 DAYS FROM THE
ISSUANCE/PURCHASE/GRANT DATE WITHIN WHICH TO MAKE THE ELECTION – NO WAIVERS, LATE FILINGS OR EXTENSIONS ARE PERMITTED. 
 3. Deliver one counterpart of
the completed election to the Company for its files. 
 4. If anyone other than you (e.g., one of your family members) will receive property that is the
subject of your election, deliver one counterpart of the completed election to each such person. 
 5. Attach one counterpart of the completed election to
your Federal income tax return for this year when you file that return next year. 

  
 -45- 

 RESTRICTED STOCK AGREEMENT 

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made as of the
                    day of         , 2013 (the “Effective Date”), by and
between Roka Bioscience, Inc., a Delaware corporation (the “Company”) and [•] (the “Participant”). 

WHEREAS, the Company maintains the Roka Bioscience, Inc. 2009 Equity Incentive Plan (the “Plan”); 

WHEREAS, the Plan permits the grant of shares of Stock of the Company, subject to certain restrictions; and 

WHEREAS, the Company desires to award the Participant the number of shares of Stock indicated below, subject to the restrictions, terms and
conditions contained in the Plan and this Agreement. 
 NOW, THEREFORE, in consideration of these premises and the agreements set forth
herein, the parties, intending to be legally bound hereby, agree as follows: 
 1. Award of Restricted Stock. Pursuant to the Plan,
the Company hereby awards the Participant [•] shares of Stock (the “Restricted Stock”), subject to the restrictions, terms and conditions set forth in this Agreement and the Plan. The purchase price of the shares of
Restricted Stock shall be $0. 
 2. Vesting. The shares of Restricted Stock will vest, and cease to be Restricted Stock hereunder, in
accordance with this Section 2. 
 (a) Time-Based Vesting. Except as otherwise provided in this Section 2,
(i) twenty-five percent (25%) of the Restricted Stock shall vest on the first anniversary of the Effective Date and (ii) the remaining seventy-five percent (75%) of the Restricted Stock shall vest in equal installments on the
last day of each of the thirty-six (36) calendar months thereafter; provided that the Participant remains in continuous employment or other service with the Company (or its Affiliates) through each applicable vesting date. 

(b) Vesting Upon Termination Without Cause or for Good Reason. If the Participant’s employment or other service with the Company
is terminated (i) by the Company without Cause or (ii) by the Participant for Good Reason at any time after the Effective Date and before the Restricted Stock is fully vested pursuant to this Section 2, all restrictions
applicable to the Restricted Stock shall lapse, and all of the Restricted Stock shall fully and immediately vest, on the date of such termination. For purposes of this Agreement, (i) “Cause” means (x) the
Participant’s willful failure to perform the Participant’s material job duties, other than a failure resulting from the Participant’s complete or partial incapacity due to physical or mental illness or impairment, (y) the
Participant’s willful act that constitutes gross misconduct and that is injurious to the Company, (z) the Participant’s willful breach of a provision of this letter agreement, (xx) the Participant’s material and willful
violation of a federal or state law or regulation applicable to the business of the Company, or (yy) the Participant’s conviction or plea of guilty or no contest to a felony, and (ii) a termination by the Participant shall be for
“Good Reason” if the Participant terminates employment or other service within 30 days following the occurrence, without 

 
the prior written consent of the Participant, of (x) a decrease in base salary, unless the Company is proportionately reducing the base salary of all of its other executive employees, as
determined by the Committee in its sole discretion, or (y) relocation of the Participant’s principal place of employment or other service over 50 miles from its location on the Effective Date. 

(c) Vesting Upon Corporate Reorganization. If a Corporate Reorganization occurs before the Restricted Stock is fully vested pursuant to
this Section 2, all restrictions applicable to the Restricted Stock shall lapse, and all of the Restricted Stock shall fully and immediately vest, on the first anniversary of such Corporate Reorganization; provided that if, prior to the
first anniversary of such Corporate Reorganization, the Participant’s employment or other service with the Company (or any successor to, or affiliate of, the Company) is terminated (i) by the Company (or any successor to, or affiliate of,
the Company) other than for Cause, or (ii) by the Participant for Good Reason, the unvested shares of Restricted Stock shall vest in full on the date of such termination. For purposes of this Agreement, “Corporate
Reorganization” shall have the meaning ascribed to such term in the Company’s Amended and Restated Certificate of Incorporation (as the same may be amended from time to time). 

(d) All Unvested Shares Forfeited Upon Termination of Service Relationship. Except as otherwise provided in this Section 2,
upon termination of the Participant’s employment or other service with the Company and its Affiliates for any reason: (i) any shares of Restricted Stock that have not, on or prior to the date of such termination, become vested will
immediately and automatically, without any action on the part of the Company, be forfeited and returned to the Company, without payment therefore by the Company, and (ii) the Participant will have no further rights with respect to those shares.
A military or sick leave or other bona fide leave shall not be deemed a termination of employment or other service, if it does not exceed the longer of (i) ninety (90) days or (ii) the period during which Participant’s
reemployment rights, if any, are guaranteed by statute or by contract. 
 3. Certificated Shares. The shares of Restricted Stock
shall be issued in the form of certificated shares. The following legend will be placed on the certificate (in addition to any other legends that may be required to be placed on such certificates pursuant to the Plan, applicable law or otherwise):

 THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE
ROKA BIOSCIENCE, INC. 2009 EQUITY INCENTIVE PLAN AND AN AWARD AGREEMENT ENTERED INTO BY THE REGISTERED OWNER AND ROKA BIOSCIENCE, INC. COPIES OF SUCH PLAN AND AGREEMENT ARE ON FILE IN THE OFFICES OF ROKA BIOSCIENCE, INC. 

If a certificate representing the shares of Restricted Stock is registered in the name of the Participant, the Company shall retain physical possession of the
certificate while the shares of Restricted Stock remain unvested and the Participant shall be required to deliver a stock power to the Company, endorsed in blank, relating to the shares of Restricted Stock. 

  
 -47- 

 4. Restriction on Transfer of Unvested Shares. Except for the forfeiture of Restricted
Stock to the Company in accordance herewith or the Plan, the Participant may not sell, pledge, assign, encumber, hypothecate, gift, transfer, bequeath, devise, donate or otherwise dispose of, in any way or manner whatsoever, whether voluntary or
involuntary, any legal or beneficial interest in any of the Restricted Stock while the shares of Restricted Stock remain unvested. After any of shares of Restricted Stock vest pursuant to this Agreement, such shares will remain subject to the terms
of the Plan. 
 5. Capital Changes. If, while any of the shares of Restricted Stock remain unvested, there occurs any merger,
consolidation, reorganization, reclassification, recapitalization, stock split, stock dividend, or other similar change in the Stock, then any and all new, substituted or additional securities or other consideration to which the Participant is
entitled by reason of the Participant’s ownership of the Restricted Stock will thereafter be included in the term “Restricted Stock” for all purposes of the Plan and this Agreement. 

6. Tax Consequences. CERTAIN FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE GRANT AND VESTING OF THE RESTRICTED STOCK, AS OF
THE EFFECTIVE DATE, ARE SUMMARIZED BELOW. THE FOLLOWING DESCRIPTION OF FEDERAL INCOME TAX CONSEQUENCES IS NECESSARILY INCOMPLETE (AS THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE). MOREOVER, THIS SUMMARY ONLY ADDRESSES THE FEDERAL INCOME TAX
CONSEQUENCES UNDER THE LAWS OF THE UNITED STATES, AND DOES NOT ADDRESS WHETHER AND HOW THE TAX LAWS OF ANY OTHER JURISDICTION MAY APPLY TO THE RESTRICTED STOCK OR TO THE PARTICIPANT. ACCORDINGLY, THE PARTICIPANT SHOULD CONSULT A TAX ADVISER
REGARDING THE FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 
 The Participant may file an
election (an “Election”) with the Internal Revenue Service (“IRS”), within 30 days of the issuance of the Restricted Stock, electing pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended
(the “Code”), to be taxed currently on any difference between the fair market value of the Restricted Stock and the purchase price of the Restricted Stock on the date of grant. Absent such an election, taxable income will be
measured and recognized by the Participant at the time or times at which the forfeiture restrictions on the Restricted Stock lapses. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. If the Participant
files an Election under Section 83(b) of the Code with the IRS, the Participant agrees to promptly furnish a copy of such Election to the Company. 

7. Additional Documents. As a condition to the receipt of the shares of Restricted Stock granted hereby: 

(a) If requested by the Company, the Participant shall execute and become a party to such agreements as the Company requires, which may
include, without limitation, the Company’s Fourth Amended and Restated Investor Rights Agreement, Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement, and/or Fourth Amended and Restated Voting Agreement; and 

  
 -48- 

 (b) the Participant agrees upon request to execute any further documents or instruments necessary
or desirable to carry out the purposes or intent of this Agreement. 
 8. Vested Shares Remain Subject to Plan. Notwithstanding the
vesting of any shares of Restricted Stock pursuant to Section 2, the Participant acknowledges and agrees that, in addition to the restrictions set forth herein, the shares will remain subject to the terms and conditions of the Plan. 

9. Representations and Warranties. By executing this Agreement, the Participant hereby represents, warrants, covenants, acknowledges
and/or agrees that: 
 (a) The Restricted Stock is being acquired for the Participant’s own account, for investment purposes only, and
not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”); 

(b) No other person (other than the Participant, his spouse and the Company) has or will have a direct or indirect beneficial interest in the
Restricted Stock; 
 (c) The Restricted Stock has not been registered or qualified under the Securities Act or any state securities laws;

 (d) There is no public market for the Restricted Stock, there can be no assurance that any such market will ever develop and, therefore,
the Participant may be required to hold the Restricted Stock indefinitely; 
 (e) In addition to complying with other similar restrictions
contained herein, the Participant will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Stock unless such interest is registered in accordance with the Securities Act and applicable state securities laws
or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is not required; and 

(f) The Company is under no obligation to register the Restricted Stock on behalf of the Participant or to assist the Participant in complying
with any exemption from registration. 
 10. General Provisions. 

(a) The Participant agrees to be bound by the terms and conditions of the Plan, which are incorporated herein by reference and which control
in case of any conflict with this Agreement. 
 (b) Capitalized terms used but not defined herein will have the same meaning as defined in
the Plan. 
 (c) This Agreement, together with the Plan, represents the entire agreement between the parties and supersedes any prior
agreement, written or otherwise, relating to the subject matter hereof. This Agreement may not be amended except by written instrument signed by each of the parties hereto. 

  
 -49- 

 (d) Any notice required or permitted to be given by either the Company or the Participant
pursuant to the terms of this Agreement shall be in writing and shall be deemed given on the date and at the time delivered via personal, courier or recognized overnight delivery service or, if sent via telecopier, on the date and at the time
telecopied with confirmation of delivery or, if mailed, on the date five (5) days after the date of the mailing (which shall be by regular, registered or certified mail). Delivery of a notice by telecopy (with confirmation) shall be permitted
and shall be considered delivery of a notice notwithstanding that it is not an original that is received. If directed to the Participant, any such notice shall be sent to the address on file with the Company, or to such other address as the
Participant may hereafter specify in writing. If directed to the Company, any such notice shall be sent to the Company’s principal executive office, c/o the Company’s Secretary, or to such other address or person as the Company may
hereafter specify in writing. 
 (e) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Participant, his
beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void. 
 (f) Either party’s
failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement.
The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances. 

(g) The grant of Restricted Stock hereunder will not confer upon the Participant any right to continue in the employment or other service of
the Company or any of its Affiliates. 
 (h) This Agreement shall be governed by and construed in accordance with the laws and judicial
decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws of Delaware or any other jurisdiction. 

(i) This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall be
deemed to be one and the same instrument. 
 [Signature Page Follows] 

  
 -50- 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first written
above. 
  

			
	ROKA BIOSCIENCE, INC.
		
	By:	 	 
		 	Name:
		 	Title:

  

			
	[PARTICIPANT]
		
		 	 

  
 -51- 

 EXHIBIT A 

ELECTION UNDER SECTION 83(b) 

OF THE INTERNAL REVENUE CODE OF 1986 

The undersigned taxpayer hereby makes an election pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, and the
Treasury Regulations thereunder (the “Regulations”), and in connection with this election supplies the following information: 
 1. The name,
address and taxpayer identification number of the undersigned are: 
 [Name] 

[Address] 

Social Security Number:
        -        -             

2. The election is being made with respect to [•] shares of common stock (the “Stock”) of Roka Bioscience, Inc., a Delaware corporation
(the “Company”). 
 3. The date on which the Stock was transferred to the undersigned was
[                    ]. The taxable year for which this election is being made is calendar year
[            ]. 
 4. The property is subject to the following restrictions: 

The above-mentioned shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the
Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. 
 Disposition of the Stock is
also subject to restrictions imposed under applicable federal and state securities laws regulating the transfer of unregistered securities. 
 5. The fair
market value of the Stock at the time of transfer (determined without regard to any lapse restriction, as defined in §1.83-3(i) of the Regulations) was $[•]. 

6. The undersigned did not pay any amount for the Stock. Therefore, $[•] (the full fair market value of the Stock stated above) is includible in
the undersigned’s gross income as compensation for services. 
 7. A copy of this election has been furnished to the Company [and to the transferee of
the Stock, if different from the taxpayer] as required by §1.83-2(d) of the Regulations. 
  

							
	Dated:                     	 		 		 	 
		 		 		 	[taxpayer signature]

 INSTRUCTIONS FOR FILING SECTION 83(B) ELECTION 

Attached is a form of election under section 83(b) of the Internal Revenue Code. If you wish to make such an election, you should complete,
sign and date the election and then proceed as follows: 
 1. Execute three counterparts of your completed election (plus one extra counterpart for each
person other than you, if any who receives property that is the subject of your election), retaining at least one photocopy for your records. 
 2. Send one
counterpart to the Internal Revenue Service Center with which you will file your Federal income tax return for the current year via certified mail, return receipt requested. THE ELECTION SHOULD BE SENT IMMEDIATELY, AS YOU ONLY HAVE 30 DAYS FROM THE
ISSUANCE/PURCHASE/GRANT DATE WITHIN WHICH TO MAKE THE ELECTION – NO WAIVERS, LATE FILINGS OR EXTENSIONS ARE PERMITTED. 
 3. Deliver one counterpart of
the completed election to the Company for its files. 
 4. If anyone other than you (e.g., one of your family members) will receive property that is the
subject of your election, deliver one counterpart of the completed election to each such person. 
 5. Attach one counterpart of the completed election to
your Federal income tax return for this year when you file that return next year. 

  
 -53- 

 RESTRICTED STOCK AGREEMENT 

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made as of the      day of
                    , 2013 (the “Effective Date”), by and between Roka Bioscience, Inc., a Delaware corporation (the
“Company”) and [•] (the “Participant”). 
 WHEREAS, the Company maintains the Roka
Bioscience, Inc. 2009 Equity Incentive Plan (the “Plan”); 
 WHEREAS, the Plan permits the grant of shares of Stock of the
Company, subject to certain restrictions; and 
 WHEREAS, the Company desires to award the Participant the number of shares of Stock
indicated below, subject to the restrictions, terms and conditions contained in the Plan and this Agreement. 
 NOW, THEREFORE, in
consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows: 

1. Award of Restricted Stock. Pursuant to the Plan, the Company hereby awards the Participant [•] shares of Stock (the
“Restricted Stock”), subject to the restrictions, terms and conditions set forth in this Agreement and the Plan. The purchase price of the shares of Restricted Stock shall be $0. 

2. Vesting. The shares of Restricted Stock will vest, and cease to be Restricted Stock hereunder, in accordance with this
Section 2. 
 (a) Time-Based Vesting. Except as otherwise provided in this Section 2, (i) twenty-five
percent (25%) of the Restricted Stock shall vest on the first anniversary of the Effective Date and (ii) the remaining seventy-five percent (75%) of the Restricted Stock shall vest in equal installments on the last day of each of the
thirty-six (36) calendar months thereafter; provided that the Participant remains in continuous employment or other service with the Company (or its Affiliates) through each applicable vesting date. 

(b) Accelerated Vesting Upon Certain Events. All restrictions applicable to the Restricted Stock granted pursuant to this Agreement
shall lapse, and all of the Restricted Stock shall fully and immediately vest, on the date of (i) a Change in Control (as such term is defined in the Employment Agreement between the Participant and the Company dated September 10, 2009
(the “Employment Agreement”)) or (ii) a termination of the Participant’s employment or other service by the Company without Cause (as defined in Section 4.01(C) of the Employment Agreement) or by him for Good Reason
(as defined in Section 4.01(E) of the Employment Agreement). 
 (c) All Unvested Shares Forfeited Upon Termination of Service
Relationship. Except as otherwise provided in Section 2(b), upon termination of the Participant’s employment or other service with the Company and its Affiliates for any reason: (i) any shares of Restricted Stock that have
not, on or prior to the date of such termination, become vested will immediately and automatically, without any action on the part of the Company, be forfeited and returned to the Company, without payment therefore by the Company,

 
and (ii) the Participant will have no further rights with respect to those shares. A military or sick leave or other bona fide leave shall not be deemed a termination of employment or other
service, if it does not exceed the longer of (i) ninety (90) days or (ii) the period during which Participant’s reemployment rights, if any, are guaranteed by statute or by contract. 

3. Certificated Shares. The shares of Restricted Stock shall be issued in the form of certificated shares. The following legend will be
placed on the certificate (in addition to any other legends that may be required to be placed on such certificates pursuant to the Plan, applicable law or otherwise): 

THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE ROKA
BIOSCIENCE, INC. 2009 EQUITY INCENTIVE PLAN AND AN AWARD AGREEMENT ENTERED INTO BY THE REGISTERED OWNER AND ROKA BIOSCIENCE, INC. COPIES OF SUCH PLAN AND AGREEMENT ARE ON FILE IN THE OFFICES OF ROKA BIOSCIENCE, INC. 

If a certificate representing the shares of Restricted Stock is registered in the name of the Participant, the Company shall retain physical possession of the
certificate while the shares of Restricted Stock remain unvested and the Participant shall be required to deliver a stock power to the Company, endorsed in blank, relating to the shares of Restricted Stock. 

4. Restriction on Transfer of Unvested Shares. Except for the forfeiture of Restricted Stock to the Company in accordance herewith or
the Plan, the Participant may not sell, pledge, assign, encumber, hypothecate, gift, transfer, bequeath, devise, donate or otherwise dispose of, in any way or manner whatsoever, whether voluntary or involuntary, any legal or beneficial interest in
any of the Restricted Stock while the shares of Restricted Stock remain unvested. After any of shares of Restricted Stock vest pursuant to this Agreement, such shares will remain subject to the terms of the Plan. 

5. Capital Changes. If, while any of the shares of Restricted Stock remain unvested, there occurs any merger, consolidation,
reorganization, reclassification, recapitalization, stock split, stock dividend, or other similar change in the Stock, then any and all new, substituted or additional securities or other consideration to which the Participant is entitled by reason
of the Participant’s ownership of the Restricted Stock will thereafter be included in the term “Restricted Stock” for all purposes of the Plan and this Agreement. 

6. Tax Consequences. CERTAIN FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE GRANT AND VESTING OF THE RESTRICTED STOCK, AS OF THE
EFFECTIVE DATE, ARE SUMMARIZED BELOW. THE FOLLOWING DESCRIPTION OF FEDERAL INCOME TAX CONSEQUENCES IS NECESSARILY INCOMPLETE (AS THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE). MOREOVER, THIS SUMMARY ONLY ADDRESSES THE FEDERAL INCOME TAX
CONSEQUENCES UNDER THE LAWS OF THE UNITED STATES, AND DOES NOT ADDRESS WHETHER AND HOW THE TAX LAWS OF ANY OTHER JURISDICTION MAY APPLY TO 

  
 -55- 

 
THE RESTRICTED STOCK OR TO THE PARTICIPANT. ACCORDINGLY, THE PARTICIPANT SHOULD CONSULT A TAX ADVISER REGARDING THE FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE
TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 
 The Participant may file an election (an “Election”) with the Internal Revenue Service
(“IRS”), within 30 days of the issuance of the Restricted Stock, electing pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended (the “Code”), to be taxed currently on any difference between
the fair market value of the Restricted Stock and the purchase price of the Restricted Stock on the date of grant. Absent such an election, taxable income will be measured and recognized by the Participant at the time or times at which the
forfeiture restrictions on the Restricted Stock lapses. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. If the Participant files an Election under Section 83(b) of the Code with the IRS, the
Participant agrees to promptly furnish a copy of such Election to the Company. 
 7. Additional Documents. As a condition to the
receipt of the shares of Restricted Stock granted hereby: 
 (a) If requested by the Company, the Participant shall execute and become a
party to such agreements as the Company requires, which may include, without limitation, the Company’s Fourth Amended and Restated Investor Rights Agreement, Fourth Amended and Restated Right of First Refusal and Co-Sale Agreement, and/or
Fourth Amended and Restated Voting Agreement; and 
 (b) the Participant agrees upon request to execute any further documents or instruments
necessary or desirable to carry out the purposes or intent of this Agreement. 
 8. Vested Shares Remain Subject to Plan.
Notwithstanding the vesting of any shares of Restricted Stock pursuant to Section 2, the Participant acknowledges and agrees that, in addition to the restrictions set forth herein, the shares will remain subject to the terms and
conditions of the Plan. 
 9. Representations and Warranties. By executing this Agreement, the Participant hereby represents,
warrants, covenants, acknowledges and/or agrees that: 
 (a) The Restricted Stock is being acquired for the Participant’s own account,
for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”); 

(b) No other person (other than the Participant, his spouse and the Company) has or will have a direct or indirect beneficial interest in the
Restricted Stock; 
 (c) The Restricted Stock has not been registered or qualified under the Securities Act or any state securities laws;

 (d) There is no public market for the Restricted Stock, there can be no assurance that any such market will ever develop and, therefore,
the Participant may be required to hold the Restricted Stock indefinitely; 

  
 -56- 

 (e) In addition to complying with other similar restrictions contained herein, the Participant
will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Stock unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such
registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is not required; and 

(f) The Company is under no obligation to register the Restricted Stock on behalf of the Participant or to assist the Participant in complying
with any exemption from registration. 
 10. General Provisions. 

(a) The Participant agrees to be bound by the terms and conditions of the Plan, which are incorporated herein by reference and which control
in case of any conflict with this Agreement. 
 (b) Capitalized terms used but not defined herein will have the same meaning as defined in
the Plan. 
 (c) This Agreement, together with the Plan, represents the entire agreement between the parties and supersedes any prior
agreement, written or otherwise, relating to the subject matter hereof. This Agreement may not be amended except by written instrument signed by each of the parties hereto. 

(d) Any notice required or permitted to be given by either the Company or the Participant pursuant to the terms of this Agreement shall be in
writing and shall be deemed given on the date and at the time delivered via personal, courier or recognized overnight delivery service or, if sent via telecopier, on the date and at the time telecopied with confirmation of delivery or, if mailed, on
the date five (5) days after the date of the mailing (which shall be by regular, registered or certified mail). Delivery of a notice by telecopy (with confirmation) shall be permitted and shall be considered delivery of a notice notwithstanding
that it is not an original that is received. If directed to the Participant, any such notice shall be sent to the address on file with the Company, or to such other address as the Participant may hereafter specify in writing. If directed to the
Company, any such notice shall be sent to the Company’s principal executive office, c/o the Company’s Secretary, or to such other address or person as the Company may hereafter specify in writing. 

(e) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Participant, his beneficiaries or legal
representatives, and any purported assignment in violation hereof shall be null and void. 
 (f) Either party’s failure to enforce any
provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both
parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances. 

  
 -57- 

 (g) The grant of Restricted Stock hereunder will not confer upon the Participant any right to
continue in the employment or other service of the Company or any of its Affiliates. 
 (h) This Agreement shall be governed by and
construed in accordance with the laws and judicial decisions of the State of Delaware, without regard to the application of the principles of conflicts of laws of Delaware or any other jurisdiction. 

(i) This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall be
deemed to be one and the same instrument. 

  
 -58- 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first written
above. 
  

			
	ROKA BIOSCIENCE, INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	[PARTICIPANT]
	
	  

  
 -59- 

 EXHIBIT A 

ELECTION UNDER SECTION 83(b) 

OF THE INTERNAL REVENUE CODE OF 1986 

The undersigned taxpayer hereby makes an election pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, and the
Treasury Regulations thereunder (the “Regulations”), and in connection with this election supplies the following information: 
 1. The name,
address and taxpayer identification number of the undersigned are: 
 [Name] 

[Address] 
 Social Security
Number:         -    -             

2. The election is being made with respect to [•] shares of common stock (the “Stock”) of Roka Bioscience, Inc., a Delaware corporation
(the “Company”). 
 3. The date on which the Stock was transferred to the undersigned was
[                    ]. The taxable year for which this election is being made is calendar year
[            ]. 
 4. The property is subject to the following restrictions: 

The above-mentioned shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the
Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. 
 Disposition of the Stock is
also subject to restrictions imposed under applicable federal and state securities laws regulating the transfer of unregistered securities. 
 5. The fair
market value of the Stock at the time of transfer (determined without regard to any lapse restriction, as defined in §1.83-3(i) of the Regulations) was $[•]. 

6. The undersigned did not pay any amount for the Stock. Therefore, $[•] (the full fair market value of the Stock stated above) is includible in
the undersigned’s gross income as compensation for services. 
 7. A copy of this election has been furnished to the Company [and to the transferee of
the Stock, if different from the taxpayer] as required by §1.83-2(d) of the Regulations. 
  

													
						
	Dated:	 	  
	 		 		 		 	  

		 		 		 		 		 	[taxpayer signature]

 INSTRUCTIONS FOR FILING SECTION 83(B) ELECTION 

Attached is a form of election under section 83(b) of the Internal Revenue Code. If you wish to make such an election, you should complete,
sign and date the election and then proceed as follows: 
 1. Execute three counterparts of your completed election (plus one extra counterpart for each
person other than you, if any who receives property that is the subject of your election), retaining at least one photocopy for your records. 
 2. Send one
counterpart to the Internal Revenue Service Center with which you will file your Federal income tax return for the current year via certified mail, return receipt requested. THE ELECTION SHOULD BE SENT IMMEDIATELY, AS YOU ONLY HAVE 30 DAYS FROM THE
ISSUANCE/PURCHASE/GRANT DATE WITHIN WHICH TO MAKE THE ELECTION – NO WAIVERS, LATE FILINGS OR EXTENSIONS ARE PERMITTED. 
 3. Deliver one counterpart of
the completed election to the Company for its files. 
 4. If anyone other than you (e.g., one of your family members) will receive property that is the
subject of your election, deliver one counterpart of the completed election to each such person. 
 5. Attach one counterpart of the completed election to
your Federal income tax return for this year when you file that return next year. 

  
 - 61 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]